Kir2 potassium channels in rat striatum are strategically localized to control basal ganglia function by Prüß, Harald
   
 
 
 
Aus dem Institut für Anatomie 
der Medizinischen Fakultät Charité 
der Humboldt-Universität zu Berlin 
 
 
 
DISSERTATION 
 
 
Kir2 potassium channels in rat striatum are strategically localized 
to control basal ganglia function 
 
 
 
Zur Erlangung des akademischen Grades 
Doctor medicinae (Dr. med.) 
 
 
vorgelegt der Medizinischen Fakultät Charité 
der Humboldt-Universität zu Berlin 
 
 
 
von 
Harald Prüß 
aus Güstrow 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dekan: Prof. Dr. Joachim W. Dudenhausen 
 
 
Gutachter:  1. Prof. Dr. A. Karschin 
  2. Prof. Dr. R. W. Veh 
  3. Prof. Dr. J. Roeper 
 
eingereicht: 16.07.2003 
Datum der Promotion: 15. 03 2004 
 CONTENTS 1 
1 INTRODUCTION 6 
1.1 Kir2 channels 6 
1.1.1 Potassium channels 6 
1.1.2 Kir – inward rectifier potassium channels 7 
1.1.2.1 Kir subfamilies 9 
1.1.3 Kir2 subfamily 9 
1.1.3.1 Electrophysiology 10 
1.1.3.2 Basic principles of inward rectification 10 
1.1.3.3 Modulation 12 
1.1.3.4 Distribution of Kir2 channels in the brain 13 
1.2 Basal ganglia 14 
1.2.1 Principle neuron and interneurons 14 
1.2.1.1 Kir current in striatal spiny neurons 15 
1.2.1.2 Cholinergic interneurons 15 
1.2.2 Patch and matrix 16 
1.2.3 Understanding the basal ganglia circuitry 17 
1.2.4 Striatal regulation of movements 19 
1.2.5 The therapeutic dilemma 20 
1.2.6 Intention of the research 21 
2 MATERIALS AND METHODS 23 
2.1 Cloning 23 
2.1.1 Selection of sequences 23 
2.1.2 Polymerase chain reaction (PCR) 24 
2.1.3 Restriction 25 
2.1.4 Agarose gel electrophoresis 25 
2.1.5 Determination of DNA concentration 25 
2.1.6 Ligation 26 
2.1.7 Generation of competent cells 26 
2.1.8 Transformation 26 
2.1.9 Preparation of plasmid DNA 26 
2.2 Protein expression and purification 27 
2.2.1 Overexpression of fusion proteins 27 
2.2.2 Protein purification 27 
2.2.3 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 28 
2.2.4 Preparative electrophoresis 29 
2.2.5 Determination of protein content 29 
2.2.5.1 BCA (Bicinchoninic acid) assay 29 
2.2.5.2 Bradford assay 29 
 CONTENTS 2 
2.3 Raising of antibodies in rabbits 30 
2.3.1 Immunization and blood taking 30 
2.3.2 Determination of antibody titer, ELISA 30 
2.3.3 Competitive ELISA 31 
2.4 Purification of antibodies 31 
2.4.1 Removal of IgM 31 
2.4.2 Removal of cross reactivity 32 
2.4.3 Affinity purification 33 
2.4.4 Chromatofocussing 33 
2.4.5 Concentration of antibodies 33 
2.5 Characterization of antibodies 34 
2.5.1 Analysis of specificity in Western Blots 34 
2.5.1.1 Preparation of brain homogenates 34 
2.5.1.2 Western Blotting 34 
2.5.1.3 Immune detection 35 
2.5.1.4 Visualization by use of alkaline phosphatase (aP) 35 
2.5.2 Analysis of specificity by transfected cells 36 
2.5.2.1 Liposome-mediated transfection 36 
2.5.2.2 Detection of transfected cells by immunofluorescence 36 
2.6 Immunocytochemistry 37 
2.6.1 Perfusion fixation of rat brains 37 
2.6.2 Rat brain slices for light microscopy 37 
2.6.3 Rat brain slices for fluorescence microscopy 38 
2.6.4 Coating of slides 38 
2.6.5 Cresyl violet staining 39 
2.6.6 Electron microscopy 39 
2.6.6.1 Immunoreaction 39 
2.6.6.2 Staining with the avidin-biotin method 39 
2.6.6.3 Gold-silver-enhancement 40 
2.6.6.4 Araldite embedding 40 
2.6.6.5 Contrasting the ultrathin sections 41 
2.6.6.6 Toluidin blue staining 41 
2.6.7 Histological analysis 41 
3 RESULTS 42 
3.1 Preparation of monospecific and affinity-purified antibodies 42 
3.1.1 Comparison of the amino acid sequences 42 
3.1.2 Recombinant fusion proteins 44 
3.1.3 Removal of IgM antibodies by gel-filtration 44 
3.1.4 Affinity purification 45 
3.2 Specificity of purified antibodies 47 
 CONTENTS 3 
3.2.1 Cross reactivity 47 
3.2.2 Competitive ELISA 47 
3.2.3 Western blot of fusion proteins 48 
3.2.4 Western blot of rat brain homogenates 49 
3.2.5 Specificity of anti-Kir2.4 antibodies 50 
3.2.6 Antibody specificity in brain sections 52 
3.3 Distribution of Kir2 channels in the rat brain 54 
3.3.1 Olfactory system 54 
3.3.2 Hippocampus 56 
3.3.3 Neocortex 56 
3.3.4 Basal ganglia and amygdala 59 
3.3.5 Thalamus 61 
3.3.6 Hypothalamus and habenula 61 
3.3.7 Substantia nigra, ventral tegmental area (VTA), superior colliculus 63 
3.3.8 Cerebellum and spinal medulla 63 
3.4 Distribution of Kir2 channels in the striatum 68 
3.4.1 Kir2 subunits are differentially distributed in the rat striatum 69 
3.4.2 Anti-Kir2.2 antibodies stain striatal fiber bundles 71 
3.4.3 Kir2.3 channels are predominantly localized in the matrix compartment 73 
3.4.4 Kir2.4 channel subunits are localized at cholinergic interneurons 75 
4 DISCUSSION 79 
4.1.1 Kir2 channel proteins are differentially expressed throughout the rat brain 80 
4.1.2 The Kir2.3 subunit is preferentially expressed in striatal matrix neurons 82 
4.1.3 Kir2.4 immunoreactivity in the striatum is most prominently displayed by the 
giant cholinergic interneurons 84 
4.1.4 Can Kir channel subunits be targets for novel therapeutic strategies? 85 
Summary 88 
References 89 
Curriculum vitae 98 
Publications 100 
Danksagung 101 
Eidesstattliche Erklärung 102 
 
 ABBREVIATIONS 4 
Abbreviations 
aca anterior commissure, anterior part 
AcbC core part of the nucleus accumbens 
AcbSh shell part of the nucleus accumbens 
ACh acetylcholine 
aP alkaline phosphatase 
BSA bovine serum albumin 
CA1-CA3 cornu ammonis 1-3 
cc corpus callosum 
CG central gray 
ChAT choline acetyltransferase 
cp cerebral peduncle 
CPu caudate-putamen 
cu cuneate fasciculus 
Cx cortex 
DA dopamine 
DAB 3,3-diaminobenzidine 
DG dentate gyrus 
ELISA enzyme-linked immunosorbent assay 
Enk Leu-enkephalin 
EPl external plexiform layer 
fi fimbria of the hippocampus 
GABA γ-amino butyric acid 
Gl glomerular layer 
Glu glutamate 
GP globus pallidus 
GPe external segment of the GP 
GPi internal segment of the GP 
Gr granule cell layer 
IG induseum griseum 
ic internal capsule 
IP interpeduncular nucleus 
 ABBREVIATIONS 5 
IPl internal plexiform layer 
ISH in situ hybridization 
Kir inwardly rectifying K+ channels 
LHb lateral habenula 
lfu lateral funiculus 
LOT lateral olfactory tract nucleus 
MG medial geniculate 
MHb medial habenula 
Mi mitral cell layer 
NGS normal goat serum 
ox optic chiasma 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PD Parkinson’s disease 
Pir piriform cortex 
Rt reticular nucleus 
SDS-PAGE SDS-Polyacrylamide gel electrophoresis 
sm stria medullaris thalami 
SNc substantia nigra pars compacta 
SNr substantia nigra pars reticulate 
SO supraoptic nucleus 
STN subthalamic nucleus 
STR striatum 
SubP substance P 
SuC superior colliculus 
TAN tonically active neuron 
Thal thalamus 
Tu olfactory tubercle 
vfu ventral funiculus 
VP ventral pallidum 
VTA ventral tegmental area 
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1 Introduction 
1.1 Kir2 channels 
1.1.1 Potassium channels 
The diversity of potassium-(K+-)specific channels far exceeds any other group of ion 
channels. The importance of this superfamily of eucaryotic channels is underlined by the 
responsibility for many regulatory processes1. 
Potassium channels contain alpha subunits and in some cases auxiliary beta subunits. The 
alpha subunit represents the integral membrane protein responsible for the conduction of 
potassium ions across the lipid bilayer2. Based on their molecular architecture different 
channel classes are distinguished (Fig. 1). Most channels are referred to as voltage-gated 
channels (Kv). They are composed of six transmembrane (TM) helices (S1-S6) and one 
pore-region (P-region), resulting in the 6TM/1P class. Furthermore, the Ca2+-dependent 
potassium channels with their additional helix, S0, belong to this class. The simplest 
structural plan of potassium channels is visible in the 2TM/1P class, named after their 
typical composition of two TM helices and one P-region and represented by the inward 
rectifier potassium channels (see next chapter). The class of the so-called ‘background’ or 
‘leakage’ channels is made up of two P-regions, hence structurally referred to as 4TM/2P 
type. 
 
Fig. 1: Alpha-subunits of distinct potassium channel classes. A) voltage-gated (Kv) K+ channels, B) 
inward rectifier (Kir) potassium channels (M1, M2: transmembrane helices, P: pore-forming region), 
C) ‘background’ or ‘leakage’ channels 
                                                 
1 SANGUINETTI, M.C. 1997 
2 BIGGIN, P.C. 2000; MINOR, D.L. 1999 
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All potassium channels require a tetrameric arrangement of four P-regions to make up a 
K+-selective filter. In contrast to the tetrameric association formed by the assembly of four 
1P channel subunits in the plasma membrane3, the 4TM/2P type only needs to dimerize to 
construct a pore. 
The structural key causing potassium selectivity of potassium channels is a highly 
conserved stretch of eight amino acids (TXXTXGYG)4. This K+ channel signature 
sequence with a GYG (Gly-Tyr-Gly) motif plays an essential role to selectively allow K+ 
ions to pass through the pore5: The carbonyl oxygen atoms of the channel pore are in the 
precise position to substitute for the oxygen of solvating water molecules. Thus, the 
entering K+ ion can strip its hydration shell at reasonably balanced energy cost. In K+ 
channels, however, the carbonyl oxygen atoms of the selectivity filter are not narrow 
enough to allow dehydration of the smaller Na+ ion. 
 
1.1.2 Kir – inward rectifier potassium channels 
Inwardly rectifying K+ (Kir) channels represent the minimal requirement for a potassium 
channel, however, it is involved centrally in physiological functions. The Kir current was 
first observed electrophysiologically in frog sceletal muscle by KATZ in 19496 and named 
an anomalous rectifier due to its unique properties, which were in contrast to the known 
voltage-dependent delayed-rectifier K+ channels. In recent years K+ channel genes were 
discovered encoding channels whose properties verify his original measurement7. In 1993, 
the primary sequence of Kir channels was identified by HO et al. who cloned the ROMK 
gene transcribed from an mRNA sequence from rat kidney cells. 
The Kir superfamily contains at least 15 members in six distinct subfamilies (Kir1, Kir2, 
Kir3, Kir5, Kir6, Kir7) that respond to many types of regulation. In the usual terminology, 
members are designated Kirx.y, whereas „x“ determines the subfamily and „y“ names the 
subtype within the subfamily8. Kir subunit cDNAs encode proteins between 327 and 501  
 
                                                 
3 GLOWATZKI, E. 1995 
4 ISOMOTO, S. 1997; MINOR, D.L. 1999; MACKINNON, R. 1998 
5 REIMANN, F. 1999; DOYLE, D.A. 1998; TAGLIALATELA, M. 1994 
6 KATZ, B. 1949; HODGKIN, A.L., HUXLEY, A.F., KATZ, B. 1952 
7 DOUPNIK, C.A. 1995; ISOMOTO, S. 1997 
8 MINOR, D.L. 1999; CHANDY and GUTMAN 1995; JAN, L.Y. 1997 
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Fig. 2: Dendrogram of the Kir family. Subfamilies, subtypes and former names. (modified from 
Reimann and Ashcroft 1999) 
 
amino acids in length. As shown in the dendrogram (Fig. 2), the channel proteins share 
about 30-40% homology among the Kir subfamilies and >60% within the subfamilies. 
The electrophysiological properties of Kir channels include the conduction of more 
current in the inward than in the outward direction. This is due to a reduced open 
probability in a depolarized membrane. Hyperpolarization above the K+ equilibrium 
potential hardly occurs under physiological conditions at the mammalian 
plasmamembrane. Consequently, despite their name, Kir channels primarily conduct 
outward potassium currents.  
Due to their peculiar properties in a particular cell, Kir channels have a key role in 
stabilizing the resting membrane potential. The Kir-mediated outward fluxes prevent 
action potential firing by small electrical stimuli. In case of strong electrical stimuli, 
however, these channels close and allow action potentials, thereby preventing massive K+ 
loss. Furthermore, modulation of these channels can alter the membrane potential, cellular 
excitability and heart rate, information processing and secretion of neurotransmitters or 
hormones9. 
                                                 
9 CHUANG, H. 1997; ISOMOTO, S. 1997, REIMANN, F. 1999 
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1.1.2.1 Kir subfamilies 
Very different physiological functions are assigned to Kir channels originating in the 
diversity of these proteins. Aside from differential cellular expression the diverse subset of 
Kir channel subtypes determines the pattern of electrical properties. 
The Kir1 subtype is a Kir channel with weak inward rectifying properties that is involved 
in transepithelial membrane transport, predominantly in the kidney, where it is important 
in homeostasis by conducting large amounts of potassium. Kir3 channels are the 
predominant mediators of metabotropic inhibition and are activated directly by Gβγ 
subunits. They influence electrical activity in neuronal, cardial and neurosecretory cells10. 
Kir4 is known to control K+ homeostasis in glial cells and the inner ear11. ATP-sensitive 
Kir6 (KATP) channels play an important role in the pancreas; they influence the control of 
insulin secretion12 in interaction with SUR (sulphonylurea receptor) subunits. Moreover, 
this channel may contribute to the cell survival during anoxia or hypoglycaemia in 
neuronal and cardiac structures. 
 
1.1.3 Kir2 subfamily 
Recent investigations produced extensive information about the molecular structure, 
electrophysiology, modulation and localization of the Kir2 inward rectifier potassium 
channels. They form tetramers of four identical (homomeric) or related (heteromeric) 
subunits that each contains two putative membrane spanning regions M1 and M2 (Fig. 
1B). The transmembrane segments form alpha helices where M1 makes up the outer and 
M2 the inner helix13. M1 as well as M2 flank a highly conserved pore-forming region 
called H5 – at this side the Kir2 subfamily shows sequence differences at only one amino 
acid residue (Fig. 7). In addition to the common molecular motif, a homotetrameric 
association of subunits is a crucial structural hallmark of Kir2 channels. Kir2.1 is an 
exception to the rule: it forms heteromultimers if coexpressed with Kir4.114. 
                                                 
10 DOUPNIK, C.A. 1995; KRAPIVINSKY, G. 1995 
11 ISHII, M. 1997; HIBINO, H. 1997, RUPPERSBERG, J.P. 2000 
12 SAKURA, H. 1995 
13 YANG, J. 1995; MINOR, D.L. 1999 
14 RAAB-GRAHAM, K.F. 1998; FAKLER, B. 1996 
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1.1.3.1 Electrophysiology 
The rectification property of the “classical” inward rectifying potassium channels (Kir2) 
includes the following components: 1) Inwardly rectifying channels show a linear 
conductance below the K+ equilibrium potential (Fig. 3). 2) The outward conductance in 
physiological conditions helps to stabilize the resting potential15. 3) Negligible outward 
currents during depolarization prevent massive potassium loss and allow prolonged 
depolarization (plateau of an action potential)16. 
 
Fig. 3: Inwardly rectifying currents recorded from a Xenopus oocyte expressing a Kir channel. 
Experimental conditions with symmetrical K+ concentrations. A) Current traces elicited by voltage 
steps from 0 mV (holding potential) to +80, +40, 0, -40, -80, -120 and –160 mV. B) Current-voltage 
relationship of the peak currents recorded from the same oocyte. 
 
Therefore, in theory cells with many of these constitutively active Kir channels and no 
additional regulation should have a relatively constant resting membrane potential, and, in 
case of depolarization, they may initiate action potentials with a long-lasting plateau17. 
 
1.1.3.2 Basic principles of inward rectification 
The ability of the strongly rectifying Kir2 channels to prevent potassium outflow was 
originally thought to be the effect of an intracellular Mg2+-mediated blockade18. Cations 
enter the channel pore and impede K+ efflux. Subsequent investigators postulated the 
intrinsic rectification caused by soluble factors different from Mg2+. Detailed 
                                                 
15 REIMANN, F. 1999; RAAB-GRAHAM, K.F. 1998 
16 ISOMOTO, S. 1997; KUBO, Y. 1993 
17 ISOMOTO, S. 1997 
18 KUBO, Y. 1993 
 INTRODUCTION 11 
characterization identified them being polyamines19 (products of L-ornithine metabolism: 
putrescine, spermidine, spermine). Spermine functions in switching Kir channels off in 
case of significant depolarization. The Mg2+ block is evidently faster than the polyamine 
effect, thus decreasing the channel-open probability20. 
Experiments focusing on combination of Mg2+-mediated block and intrinsic polyamine 
gating revealed a competition between these ions. The finding led to the assumption that 
these substances bind at the same single site of the Kir channel21. Mutagenesis studies 
have 
 Fig. 4: Model of channel block by polyamines. A) Spermine and Mg2+ directly block the pore by 
binding at residue D172. B) E224 and E299 are discussed controversially: spermine binding at residue 
E224 leads to a high affinity blocking complex (Lee et al. 1999), or intermediate binding at 
E224+E299 level facilitates the entry of spermine but does not plug the pore (Kubo and Murata 2001). 
characterized at least two negatively charged amino acid residues as regulators of inward 
rectification (Fig. 4, 5). Aspartic acid D172 in the second transmembrane domain (M2) as 
well as the widely separated aspartic acid D260, glutamate E224 and E299 in the C-
terminal region seem to be key positions in the strong inward rectifier Kir222.  
A recent X-ray crystallography analysis reveals many amino acids lining the pore yet to be 
altered by mutagenesis23. Their further conclusions display the voltage-dependent 
rectification in a simple fashion: The lining of the cytoplasmic pore contains polar, 
negatively charged amino acid side chains interspersed with hydrophobic amino acid side 
chains. These amino acids exactly match with polyamines, which are long chains of 
positive amino groups separated by hydrophobic spacers. 
                                                 
19 LOPATIN, A. 1994; FAKLER, B. 1995 
20 DOUPNIK, C.A. 1995; RUPPERSBERG, J.P. 2000 
21 YAMASHITA, T. 1996 
22 YANG, J. 1995; LU, Z. and MACKINNON, R. 1994; STANFIELD, P.R. 1994, LEE, J.-K. 1999, KUBO, Y. and 
MURATA, Y. 2001 
23 NISHIDA, M. AND MACKINNON, R. 2002 
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1.1.3.3 Modulation 
 
Fig. 5: Synopsis of Kir2 channel modulations. For detailed explanation of (a) to (r) see table 1. 
 
Despite their rather simple structure, members of the Kir2 subfamily play a central role in 
many physiological processes. They depend prominently on multiple regulators24 such as 
pH, G-proteins, kinases, polyamines, nucleotides and phospholipids, but also on 
pharmaceutical products like the immunosuppressant cyclosporin A25. Due to the 
complexity of modulators, a synopsis is given (Fig. 5) summarizing the most important 
factors with their site of interaction. Moreover, it underlines the extraordinary significance 
of this information with respect to normal and pathophysiological conditions. 
 
 
 
 
 
 
                                                 
24 ISOMOTO, S. 1997; REIMANN, F. 1999; QU, Z. 1999/2000; COHEN, N.A. 1996; ZHU, G. 1999;             
HUANG, C.-L. 1998; COULTER, K.L. 1995; NAMBA, N. 1996; WISCHMEYER, E. 1998 
25 CHEN, H. 1998 
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Table 1: Kir2 channel modulators. 
modulator channel effect Kir2.1 Kir2.2 Kir2.3 Kir2.4 reference 
Mg2+, spermine inward rectification + (r)    Yang 1995, Lee 1999 
Lee 1999 
Kubo 2001 
pH extracellular inhibition   + (r) + (h) Hughes 2000 
pH intracellular inhibition – (r)  + (r)  Qu 1999, Qu 2000 
ATP inhibition –  +  Collins 1996 
PIP2 activation + (r)    Huang 1998 
G-protein suppression –  +  Cohen 1996b 
M1 ACh receptor inhibition –  +  Chuang 1997 
5HT1A inhibition +    Cohen 1996a 
Substance P suppression     Stanfield 1985 
PSD-95 binding cytosceletal 
binding 
+  +  Cohen 1996a 
PKC 
phosphorylation 
decreased activity +  + (r) + (h) Kir2.1: Doupnik 1995, 
Kir2.3: Zhu 1999b, Kir2.4: 
Hughes 2000 
Asn glycosylation glycosylation    + (h) Hughes 2000 
tyrosine kinase  phosphorylation    + (h) Hughes 2000 
cAMP/cGMP 
dependent 
phosphorylation   + (r) + (h) Kir2.3: Cohen 1996a 
Kir2.4: Hughes 2000 
endoplasmic 
reticulum 
ER-export 
consensus 
sequence 
FxYENEV 
+ (r)    Stockklausner 2001 
+ = effect, – = no effect, (r) = rat, (h) = human 
 
1.1.3.4 Distribution of Kir2 channels in the brain 
Kir2 channels are expressed by diverse cells including neuronal cells, myocytes, blood 
cells, sceletal muscle fibers, macrophages, osteoclasts, endothelial and placental cells26. 
Most information about distribution of Kir channels is based on in situ hybridization 
experiments27. In general, Kir2 mRNAs are widely distributed throughout the rat brain. 
Kir2.1, Kir2.2 and Kir2.328 are expressed in dentate gyrus, olfactory bulb, caudate 
putamen, and piriform cortex (see discussion). Kir2.1 and Kir2.3 are less prominent in 
thalamus, cerebellum and brainstem, where Kir2.2 displays a prominent expression 
pattern. The Kir2.4 subunit29 seems to be strongly expressed in several nuclei of medulla 
and brainstem. 
                                                 
26 DOUPNIK, C.A. 1995; PERILLAN, P.R. 2000; RAAB-GRAHAM, K.F. 1998; FALK, T. 1995; KARSCHIN, C. 
1999; KOYAMA, H. 1994 
27 MORISHIGE, K.-I. 1993; HORIO, Y. 1996; KARSCHIN, C. 96; BREDT, D.S. 95; TÖPERT, C. 98; FALK, T. 95 
28 KARSCHIN, C. 1999; KARSCHIN, C. 1996; HORIO, Y. 1996; FALK, T. 1995 
29 TÖPERT, C. 1998; TÖPERT, C. 2000 
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So far, only few studies investigated the distribution of Kir proteins in the mammalian 
brain by using specific antibodies30. Up to date, available data are largely restricted to 
brain nuclei at the cellular level. Consequently, a more detailed localization at the 
subcellular and regional level in cells linked to physiological or clinical questions are to 
the fore.  
 
 
1.2 Basal ganglia 
The basal ganglia are a major neural system of subcortical telencephalic brain nuclei. 
They are involved in movement disorders, motivated behavior and drug addiction; they 
are strongly interconnected with each other as well as linked to most elements of the 
mammalian brain. The main structures are the striatum (STR, caudate nucleus and 
putamen), pallidum (GP), substantia nigra (pars compacta (SNc) and pars reticulata 
(SNr)), ventral tegmental area (VTA) and subthalamic nucleus (STN). The pallidum is 
further divided into an external pallidum (GPe, corresponding to the globus pallidus in rat) 
and an internal segment (GPi, corresponding to the entopeduncular nucleus in rat). 
 
1.2.1 Principle neuron and interneurons 
Simple neuroanatomical techniques (cresyl violet) characterize the homogeneous structure 
of the striatum, predominantly composed of medium-sized spiny neurons and perforated 
by numerous fiber bundles. Using axon tracing and immunocytochemistry, the 
neostriatum seems to be a complex mosaic of connections, cell morphologies and 
neurochemical markers. Aside from spiny projection neurons, at least four classes of 
interneurons contribute to the neuronal framework. 
The principal medium-sized spiny neuron represents over 90% of neurons in the rodent 
neostriatum31. The cell bodies range from 12-20 µm in size and these projection cells 
show the highest spine density in the brain and have highly collateralized axons. Since the 
                                                 
30 RAAB-GRAHAM, K.F. 1998; COHEN, N.A. 1996; PERILLAN, P.R. 2000 
31 KAWAGUCHI, Y. 1995, WILSON, C. 1998 
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spiny neurons are the main output of the striatum, the principal neuron is the primary 
circuit element. In addition, most of the incoming axons target their spines. 
After identification as projection cells in the 1970s, the projections of spiny neurons were 
examined. Approximately one half of these cells forms the direct pathway (see chapter 
1.2.3.), while the remaining neurons project via the indirect pathway32. Both 
subpopulations form GABAergic synapses, but these two classes of spiny neurons are 
different in their cytochemical profile containing either enkephalin or substance P33. No 
preferential distribution is present in the striatum. 
 
1.2.1.1 Kir current in striatal spiny neurons 
Medium spiny neurons move between two membrane states, referred to as the down-state 
and the up-state34. During the down-state, the membrane potential remains at relatively 
hyperpolarized potentials (-85 mV) and the spiny cells do not generate action potentials. 
In contrast, during the episodes of depolarization (up-state) the membrane potential 
resides just below threshold (-60 mV) and action potential discharge may occur35. The 
transition to the depolarized state depends on temporally coherent activity. 
The membrane conductance in the hyperpolarized down-state is mainly determined by 
inwardly rectifying Kir2 potassium channels36. These channels help to hold the neuron 
close to the K+ equilibrium potential. Thus, the Kir current reduces the effect of 
temporally or spatially isolated excitatory synaptic input and acts like a barrier for 
asynchronous excitatory potentials. In up-states, the influence of Kir channels is minimal 
due to their inward rectification properties. 
 
1.2.1.2 Cholinergic interneurons 
Up to 60 µm in length, cholinergic interneurons are the main source of the high 
acetylcholine (ACh) levels in the striatum and neurotransmission of these cells is of 
central importance for the final striatal output. The giant interneurons account for less than 
                                                 
32 PARENT, A. 2000; GERFEN, C. 1992; AIZMAN, O. 2000 
33 PENNY, G.R. 1986; KITA, H. 1988; GROENEWEGEN, H.J. 1996; KAWAGUCHI, Y. 1990 
34 WILSON AND KAWAGUCHI 1996; NICOLA 2000 
35 NISENBAUM, E.S. 1995; WILSON, C. 1993 
36 NICOLA, S.M. 2000; MERMELSTEIN, P.G. 1998 
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2% of cells in the striatum. They can be identified by staining for choline acetyltransferase 
(ChAT)37, the enzyme for synthesis of the transmitter acetylcholine from acetyl-CoA and 
choline. Communication between the striatal compartments (see chapter 1.2.2.) is thought 
to be performed by very extensive axonal fields and widespread dendritic trees of 
cholinergic interneurons. Due to their tendency to preferentially arborize in the matrix, the 
cholinergic cells seem to transmit information from the patch to the spiny projection 
neurons in the matrix38 that represent the main synaptic target of cholinergic interneurons. 
Aside from some dopaminergic input, cholinergic interneurons are mainly innervated by 
cortical and thalamic projections39.  
The capability of firing irregularly in a spontaneous tonic pattern named these cells 
tonically active neurons (TANs). In contrast to spiny neurons, the cholinergic cells 
integrate the effects of only a small numbers of afferent axons40. TANs exhibit a pause in 
firing, which is thought to represent the physiological correlate of motor learning and 
rewarded movements41. Therefore, cholinergic neurons play a pivotal role for striatal 
output and learning in normal and pathophysiological conditions. 
 
1.2.2 Patch and matrix 
Both in the primate and rodent neostriatum, two compartments can be distinguished. The 
so-called cell islands in primates correspond to striosomes = patches in the rat, where they 
occupy approximately 10% of striatal space42. The areas surrounding the patches are 
called matrix. The compartmental organization can be distinguished using biochemical 
markers such as transmitters, related enzymes or metabolites, and transmitter binding and 
uptake sites. The patchy organization of µ-opiate receptors as first reported by PERT et al. 
in 1976 provided an excellent and constant marker of the patch compartment in the 
embryonic, young and adult rat, and throughout both the dorsal and ventral striatum43. 
Another marker is acetylcholinesterase (AChE) that is more intensively detectable in the 
                                                 
37 BOLAM, J.P. 1984 
38 VAN VULPEN, E.H.S. 1998; KAWAGUCHI, Y. 1995 
39 CALABRESI, P. 2000; WILSON, C.J. 1998 
40 WILSON, C. 1998; KAWAGUCHI, Y. 1995 
41 BENNETT, B.D. 2000; WATANABE, K. 1998; KAWAGUCHI, Y. 1995; RAZ, A. 1996 
42 TRYTEK, E.S. 1996; WILSON, C. 1998; BOLAM, J.P. 1988 
43 PERT, C.B. 1976; HERKENHAM, M. and PERT, C.B. 1981; DESBAN, M. 1993; CABOCHE, J. 1991 
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matrix. The AChE-poor striosomes form three-dimensional labyrinths and correspond to 
the µ-opiate receptor patches44. 
With respect to the neurochemical differences of patch and matrix, it seems plausible to 
assume functional heterogeneity. Separate sets of dopamine midbrain neurons target the 
two compartments, respectively. Dopaminergic afferents from part of the SN project to 
striosomes, whereas much of cell group A8 (retrorubral area) projects to the matrix45. It 
suggests a differential regulation between striosome-related versus matrix-related basal 
ganglia circuits. 
Outputs are as distinct as inputs: neurons from the matrix project to the SNr via direct and 
indirect pathway. In contrast, patches preferentially project to dopaminergic nigrostriatal 
neurons in the SNc (Fig. 6). They may either inhibit dopaminergic neurons in SNc, or 
disinhibit them through inhibition of GABAergic interneurons.  
The local axon collaterals of spiny neurons as well as their dendrites are restricted to the 
compartment of their parent cell body46. In contrast, dendrites of cholinergic interneurons 
cross the compartments. Their axon collaterals are denser in the matrix, whereas cell 
bodies and dendrites are approximately equally distributed47. 
 
1.2.3 Understanding the basal ganglia circuitry 
Observations of humans afflicted with degenerative diseases of basal ganglia were 
essential for the understanding of the basic circuitry. Diseases related to basal ganglia 
include Parkinson’s disease (PD), Tourette’s syndrome, schizophrenia, Huntington’s 
chorea and hemiballism. 
Parkinson’s disease is the most frequent disorder of the basal ganglia caused by loss of 
dopaminergic neurons and resulting depigmentation in the substantia nigra. Typical 
features are extreme underactivity, poverty of movement (hypokinesia), infrequency of 
swallowing, abnormal postural reflexes, absence of arm swing in walking and reduced 
velocity of movement (bradykinesia) up to inability to walk forwards (freezing). Also firm 
                                                 
44 GRAYBIEL, A. 1990 
45 DAHLSTROM, A. and FUXE, K. 1964; GRAYBIEL, A. 1990; EBLEN, F. 1995; SURMEIER, D.J. 1996 
46 GERFEN, C. 1992; WILSON, C. 1998 
47 KAWAGUCHI, Y. 1995; GRAYBIEL, A. 1990 
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and tense muscles (rigidity) and a low-frequency resting tremor are seen in many patients, 
often beginning in one limb and spreading to one side48. 
Both the features of the disease and the success of available therapies can be understood to 
a remarkable degree, when the neuronal circuits are considered, on which movements are 
based. Cerebral cortex and basal ganglia are the main structures of movement planning 
and program selection (Fig. 6).  
Neuronal transmission through the basal ganglia is performed in circuits. Beginning at the 
cerebral cortex most information enters the basal ganglia at the level of the striatal 
projection neurons. The axons form asymmetrical excitatory glutamatergic synapses 
primarily on the head of dendritic spines. Afterwards, the circuit continues to the 
GABAergic neurons located in GPi (entopeduncular nucleus in rats) and SNr. This so-
called direct pathway facilitates a certain movement. Another half of spiny projection 
neurons make use of an alternative route also including GPe and STN (indirect pathway). 
It suppresses a movement in contrast to the direct pathway. Glutamatergic projections 
from the subthamalic nucleus to GPi/SNr are thought to excite the GPi, consequently 
increasing pallidal inhibition of the thalamus49. Both GPe and STN influence all striatal 
structures and are affected by cortical and thalamic projections50. 
From GPi/SNr the circuit proceeds to the output nuclei of basal ganglia, i.e. ventral 
anterior, ventromedial and mediodorsal thalamic nuclei and superior colliculus. These 
structures are under tonic GABAergic inhibition by pallidal and nigral spontaneous firing. 
Finally, the cortex receives excitatory input from this complex circuit.  
This model of circuitry contains multiple parallel basal ganglia-thalamocortical circuits 
(motor, oculomotor, dorsolateral prefrontal, lateral orbitofrontal and anterior cingulate). 
Depending on the cortical input, three striatal territories were distinguished (motor, 
associative and limbic or ventral striatum)51. Neither the striatal subdivision nor the 
specific loops are supposed to be considered as strictly bordered or without neuronal 
interactions. Recent studies52 suggest an information flow through the basal ganglia not by 
segregated parallel circuits, but by an ascending spiral interconnecting different functional 
regions.  
                                                 
48 BERGMANN, H. 1998 
49 GROENEWEGEN, H.J. 1996; KAWAGUCHI, Y. 1990 
50 PARENT, A. 2000; PARENT, A. 1990; GROENEWEGEN, H.J. 1996 
51 ALEXANDER, G.E. 1986, 1990; BAEV, K.V. 1995; JOEL, D. and WEINER, I. 2000; FLAHERTY, A.W. 1991 
52 HABER, S.N. 2000 
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Information flow proceeds from limbic to associative, further to motor domains of the 
striatum via the midbrain dopamine cells. Each component disinhibits the next step in the 
spiral and inhibits itself by a feedback loop. 
 
 
Fig. 1: Schematic representation of the neuronal circuitry underlying basal ganglia function. For 
details see text. 
 
1.2.4 Striatal regulation of movements 
Basal ganglia seem to play a selecting rather than initiating role in motor activity. 
Neuronal activity in the striatum is thought to be a “movement template” whose 
occurrence could become facilitated or suppressed. To perform a certain movement, 
inhibition of GPi/SNr is essential (Fig. 6). Therefore, activation of the direct pathway as 
well as suppression of the indirect pathway is required to interrupt the tonic pallidal/nigral 
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inhibition. Consequently, this disinhibition of thalamic neurons would result in excitation 
of the cortex and the appearance of motor action. 
The efficacy of the direct and indirect pathway is regulated by two striatal key structures: 
the patch compartment and the cholinergic interneuron. 
The dopaminergic neurons of the substantia nigra pars compacta (SNc) target spines of 
striatal projection neurons and are thought to control the cortical inputs synapsing on the 
same spine head53. The SNc neurons facilitate the direct pathway via D1 receptors and 
inhibit the indirect pathway via D2 receptors, thus synergistically favoring movements. 
The dopaminergic SNc neurons are controlled by the patch compartment, emphasizing the 
striking functional differences between the two striatal areas. 
In contrast, giant cholinergic interneurons facilitate the indirect pathway via muscarinic 
M1 receptors and inhibit the direct pathway via M4 receptors. In animal models of 
Parkinson’s disease, persistent oscillatory activity of cholinergic interneurons can be seen 
instead of normal tonic firing, underlining the functional and clinical relevance of these 
neurons54.  
1.2.5 The therapeutic dilemma 
Effective therapies to treat the motor impediments in Parkinson´s disease described above 
have been available for a long time. Presently, therapeutic intervention in younger patients 
starts with dopamine agonists, which often improve the motor impediments. With 
progression of the disease addition of L-dopa (L-dihydroxy-phenylalanine) is necessary 
and very effective even in advanced states of the disease. The traditional choice of 
cholinergic antagonists is less important today and restricted to the relief of tremor. It 
remains essential, however, in order to achieve a marked improvement in dyskinesia 
during neuroleptic therapy. However, even an excellent therapeutic regime implies a 
medical dilemma: many side effects are the patient’s price for temporary motor 
improvement. Dryness of the mouth, blurring of vision and constipation are the first 
troubles in many patients making use of anticholinergics, and nausea as well as sickness 
are the primary problems under L-dopa therapy. 
                                                 
53 CEPEDA, C. 1998; GRAYBIEL, A.M. 1990; BERGMANN, H. 1998; GERFEN, C.R. 1989; GROVES, P.M. 1995 
54 RAZ, A. 1996 
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L-dopa application also causes more troublesome complications. Induction of involuntary 
movements such as grimacing, lingual-labial dyskinesia and restlessness, limits the use. 
Consequently, therapeutic skill is required to maintain the fine balance between a mobile 
patient and some degree of dyskinesia. Hallucinations, confusion and impairment of 
memory limit the advantages of cholinergic antagonists. Moreover, long-term treatment 
cannot prevent the advance of Parkinson’s disease, and finally, L-dopa therapy causes 
severe dose-response fluctuations (on-off-phenomenon) as well as uncontrollable 
dyskinesia, thus terminating the pharmacological management. 
 
1.2.6 Intention of the research 
Current therapies of Parkinson’s disease as described above rely on manipulation of 
transmission at these striatal key positions. Other targets have to be found to develop new 
therapeutic strategies for treating motor deficits. In principle, every step of the signal 
transduction cascade seems to be a possible approach for new pharmacological regimes. 
Special attention must be paid to those biological functions, which are performed by a 
variety of effector proteins in different cell types. This diversity may allow addressing 
individual neurons and individual neuronal circuits separately. 
With respect to their enormous diversity (see chapter 1.1.3.3.), potassium channels may 
represent suitable targets for therapeutic intervention. The success of this type of strategy 
is well documented in cases like the treatment of cardiac arrhythmias and diabetes (see 
discussion). For the treatment of Parkinson’s disease or related disorders, however, 
promising effects may be expected only if the channels are selectively or at least 
predominantly expressed in one of the key motor structures. Only in this case, selective 
channel activation or inhibition may specifically influence the outcome of movements. 
In a first step to throw light on the possible involvement of Kir2 channels in striatal 
pathways, the present study aimed to: 
(1) analyze the protein distribution of all members of the Kir2 channel subfamily in the rat 
brain. 
(2) study whether members of the Kir2 channel protein family, if present in the rat basal 
ganglia, display a similar or distinct basal ganglia localization. 
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(3) learn whether any member of the Kir2 subfamily is predominantly found at the striatal 
key motor structures. 
It may be expected that the results of this study increase the understanding of specific 
interactions that take place in the striatum and ultimately determine the output of the basal 
ganglia. The knowledge of the detailed pattern of Kir2 channel distribution is necessary to 
understand electrophysiological influences at the subcellular level as well as the 
processing within the striatum. Consequently, the study may be helpful in further 
examinations to clarify how a disturbed striatal circuitry causes the symptoms of diseases 
of the basal ganglia. 
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2 Materials and Methods 
2.1 Cloning 
2.1.1 Selection of sequences 
Selection of suitable sequences of the amino acid order is necessary to produce highly 
specific antibodies to investigated channel proteins. I gratefully appreciate the cDNAs of 
Kir2.1 to Kir2.4 supplied to me by Wischmeyer (2.1), T. Falk (2.3), Kurachi (2.2) and C. 
Töpert (2.4). 
 
Table 2: vectors 
 Kir2.1 Kir2.2 Kir2.3 Kir2.4 
accession code L48490 X78461 X87635 AJ003065 
species rat rat rat rat 
vector of original DNA pSVSport 1 Bluescript(SK–) Bluescript(SK+) pSVSport 
number of amino acids  427 427 445 434 
 
The suitable sequences were determined by comparing the homologies between the 
potassium channels of the Kir2 subfamily (Fig. 7). It was shown by use of the program 
DNASIS that the greatest difference in amino acid sequence exists at the carboxy-terminal 
fragments. Consequently, selection of this region is most promising for raising subtype 
specific antibodies. Selected 50-70 amino acids (Fig. 7) were subcloned into two different 
vectors. The first vector was used to produce the fusion protein for rabbit immunization 
and subsequent antibody production, whereas the second vector was utilized for antibody 
purification (see table 3). 
 
MacDNASIS 03.02 - Hitachi Software Engineering America, USA 
vectors: 
pGEX-4T-1 - Pharmacia Biotech, Sweden 
pQE-40, pet32b - Qiagen, Hilden 
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Table 3: Primer and restriction enzymes (restriction sites underlined) 
 Kir2.1 Kir2.2 Kir2.3 Kir2.4 
amino acid sequence 376-427 372-421 372-439 395-434 
sequence 5´-Primer TAG GAT CCC 
AAA GAG GAA 
GAG GAC AGT 
(27-mer) 
CA TGC GGT 
ACC CTA GCC 
TTC CTG AGC 
(26-mer) 
CA TGC GGT 
ACC TTG GCC 
CTC ATG AGC 
(26-mer) 
TGT CAT CTC 
GAG GAA GGG 
GTG TCA 
(24-mer) 
sequence 3´-Primer CGC GCT CGA 
GTC ATA TCT 
CCG ATT CTC 
(27-mer) 
TA ATT AAG 
CTT GTA GGG 
CCG CTC AAG 
(26-mer) 
TA ATT AAG 
CCT GTA AGA 
AAT GTT GTC 
(26-mer) 
AGA ATG GAT 
CCG CGC TGA 
GCT GCT 
(24-mer) 
expression vector     
for immunization pGEX-4T-1 pQE40 pQE40 pGEX-4T-1 
for affinity purification pet32b pet32b pet32b  
restriction sites BamHI 
XhoI 
Asp718 
HindIII 
Asp718 
HindIII 
XhoI  
BamHI 
 
2.1.2 Polymerase chain reaction (PCR) 
Polymerase chain reaction is a process of DNA amplification, where the nucleic acid helix 
is heated and melted into single strands. At appropriate annealing temperatures the added 
primers hybridize to their respective strand and act as the starting point for DNA 
polymerase. Multiple repetitions of this process generate amplification of the selected 
Kir2 DNA sequences. 
 
PCR mixture for 100 µl: PCR cycle:  
3 µl plasmid DNA (0.5 µg) 1. Denaturation 45 sec at 95°C 
1.5 µl 5´ primer (150 µM) 2. Hot start addition of polymerase 
1.5 µl 3´ primer (150 µM) 3. Primer binding 45 sec at 61°C 
1.5 µl dNTP mix (25 mM) 4. Strand synthesis 20 sec at 72°C 
10 µl 10x PCR buffer 5. Stop 45 sec at 95°C 
80.5 µl H20 6. Repetition from 3. (25 cycles) 
 7. End 60 sec at 56°C 
+ 2 µl Pfu-polymerase (2.5 U)  10 min at 72°C 
   
The PCR product was cleaned with the “Qiagen PCR Purification Kit”. The successful 
amplification was further controlled by using electrophoresis on agarose gels and 
sequenced for confirmation of the correct nucleic acid sequence.  
Thermocycler, Omn-E - Hybaid, USA 
Pfu-polymerase, 10x PCR buffer - Stratagene, USA 
dNTP mix(2´-Desoxyribonucleotid-5´-triphosphat, A,C,T,G) - Boehringer, Mannheim 
Primer - MWG-Biotech, Ebersberg 
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2.1.3 Restriction 
Addition of corresponding restriction enzymes to the DNA (vector and insert) results in its 
being cut at the available restriction sites (see table 3). Therefore, compatible “sticky 
ends” were generated in both vector and PCR product that become connected in the 
subsequent ligation. Restriction was performed at 37 °C for 90 minutes and followed by 
purification of DNA with “Qiagen PCR Purification Kit” / user’s manual. 
HindIII, Asp, BamHI - MBI Fermentas (Latvia), Boehringer, Mannheim 
 
2.1.4 Agarose gel electrophoresis 
To control the successful restriction, the PCR products were separated in 2 % and the 
uncut vector in 8 % agarose gel (with 0.5 µg/ml ethidium bromide) in 1x TAE. 
Electrophoresis was run at 100 V. During this process ethidium bromide intercalates into 
the DNA and thus, DNA bands can be visualized due to fluorescence under ultraviolet 
light. 
1 x TAE: 40 mM Tris acetate, 1mM Na2EDTA, pH 7.6 in H2O 
Agarose - Biozym, Hess.Oldendorf 
Ethidium bromide - Sigma, USA 
Marker - MBI Fermentas, Latvia 
6 x Sample buffer - MBI Fermentas, Latvia 
Electrophoresis chamber - Kreutz Laborgeräte, Reiskirchen 
Power supply unit, Power Pac 200 - Bio-Rad, USA 
 
2.1.5 Determination of DNA concentration 
Concentration of DNA was calculated from the optic density OD260nm, measured against 
water. Double stranded DNA of a 50 µg/ml concentration has a value of 1. The quotient 
from OD260nm to OD280nm indicates the purity of the DNA. Values greater than 1.8 are 
indicative of highly purified DNA. 
UV-Photometer UV-1202 - Shimadzu, Japan 
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2.1.6 Ligation 
Ligation was performed overnight at 15 °C mixing vector DNA and insert DNA. T4-DNA 
ligase was then inactivated by incubation at 65 °C for 10 minutes. 
Ligation mixture: 
10 µl vector DNA 
12 µl  insert DNA 
3 µl  10 x ligase buffer - MBI Fermentas, Latvia 
5 µl  T4-DNA ligase (1 U/µl) - MBI Fermentas, Latvia 
filled up with Millipore H2O to 30 µl 
 
2.1.7 Generation of competent cells 
20 ml LB culture medium were incubated with competent bacteria. During the phase of 
logarithmical growth – at OD600nm between 0.4 and 0.6 at 37 °C on a shaker – cells were 
extracted and centrifuged for 10 minutes at 5000 x g and 4 °C. The pellets were resolved 
in 20 ml ice-cold and autoclaved CaCl2 solution (70 mM CaCl2, 10 mM Tris, pH 8.0) and 
placed on ice for an hour. After new centrifugation for 10 minutes at 5000 x g and 4 °C 
bacteria were resolved in 2 x 1 ml CaCl2 solution and stored on ice. Finally, bacteria were 
frozen in liquid nitrogen and stored at -80 °C. 
LB-Medium - Gibco Brl, Life Technologies, GB 
Centrifuge - Beckman, USA 
 
2.1.8 Transformation 
A mixture of 100 µl of competent cells with 20 µl ligated DNA was incubated on ice for 
20 minutes under repeated careful shaking, followed by heating in water at 42 °C for 90 
seconds and cooling down for 2 minutes on ice. This procedure led to transformation of 
DNA into competent cells. Afterwards 1 ml LB culture medium was added and the 
mixture was shaken for 45 minutes at 37 °C. The transformed cells were crossed out on 
LB Agar (50 µg/ml Ampicillin) in dilutions from 100-10 µl, overnight at 37 °C. 
LB-Agar - Gibco Brl, Life Technologies, GB 
Ampicillin sodium - Grünenthal, Stolberg Preparation of plasmid DNA 
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Individual grown clones on the agar plate were selected and each brought into 4 ml LB 
culture medium (100 µg/ml Ampicillin) and incubated at 37 °C over night. Purification 
was performed with the “Qiagen Qiaprep SpinPlasmid Kit” (principle of alkaline lysis). 
Afterwards correctness of transformation was controlled with restriction of the plasmid 
(same procedure as after ligation) and separation in agarose gel electrophoresis. 
 
2.2 Protein expression and purification 
2.2.1 Overexpression of fusion proteins 
Successfully transformed clones grew in 6 ml LB each (+ampicillin) at 37 °C overnight on 
the shaker (230 rpm), were brought into 500 ml LB culture medium and matured to an 
OD600 of 0.5-1. The protein expression was induced by adding 1 mM final concentration 
IPTG (Isopropyl-β-D-thiogalactosid; Roth, Karlsruhe) and subsequent shaking for 4 
hours. Finally, cells were harvested with the centrifuge at 5000 g for 20 minutes at 4 °C. 
 
2.2.2 Protein purification 
The pellet of expressed protein was resolved in 1 x PBS (for pGEX vector) or lysis buffer 
(for PQE-40 and pet32b vector) and lysed by sonification and addition of Trition X-100 
(only pGEX vector) to a final concentration of 1 % while being shaken for 60 minutes. 
Afterwards cell debris was precipitated by centrifugation at 10000 x g for 30 minutes. 
Glutathione-Sepharose 4b (for pGEX vector) or Ni-NTA solution (for PQE-40 and pet32b 
vectors) was added to the supernatant containing the solved proteins. The suspension was 
incubated at room temperature for 60 minutes and then washed 5 times in PBS on a 
column. Eventually the proteins were eluted 5 times with 500 µl glutathione buffer (pGEX 
vector) or elution buffer (PQE-40 and pet32b vectors). The proteins were dialysed against 
PBS at 4° C overnight.  
 
Lysis buffer: NaH2PO4, pH 8 50 mM  Glutathione buffer:  
 NaCl 300 mM Glutathione 10 mM 
 Imidazol 10 mM Tris-HCl, pH 8 50 mM 
Washing buffer = Lysis buffer with 20 mM Imidazol 
Elution buffer = Lysis buffer with 250 mM Imidazol 
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Glutathione-Sepharose 4B - Pharmacia, Sweden 
Ni-NTA - Qiagen, Hilden 
 
2.2.3 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
The method of LAEMMLI (1970) was used for electrophoretical separation of proteins on 
10 % or 12 % SDS-PAGE polyacrylamid gels. The probes were dissolved in 4 x Laemmli 
buffer and heated at 95 °C for 5 minutes. Gels were loaded with the probes and a marker 
(Fig. 8). Separation of proteins was performed at 100 V in the stacking gel and at 200 V in 
the separation gel in the gel chamber filled with 1 x running buffer (0,3 % Tris/HCl, 1.44 
% glycine, 0.1 % SDS). 
 
 12% separation gel 4% stacking gel 
30% Acrylamid 3.88 ml 810 µl 
2% Bisacrylamid 1.8 ml 375 µl 
5x separation/collection 
gel buffer 
2 ml separation gel buffer 
(Tris 1.88 M, SDS 0.5%, pH 8.8) 
1 ml collection gel buffer 
(Tris 630 mM, SDS 0.5%, pH 
6.8) 
H2O 2.32 ml 2.815 ml 
APS (10%) 50 µl 25 µl 
TEMED 10 µl 5 µl 
 
4 x Laemmli buffer: 10 % (w/v) ß-Mercaptoethanol 
 4 % (w/v) SDS 
 2 % (w/v) Bromphenolblau 
 20 % (w/v) Glycerol 
 250 mM Tris-HCl, pH 6.8 
 
Electrophoresis chamber Mini-Protean II - Bio-Rad, USA 
LMW Standard - Pharmacia Biotech, Sweden 
Power supply unit, Power Pac 200 - Bio-Rad, USA 
Rainbow protein molecular weight marker - Amersham Life Science, UK 
TEMED (N,N,N´,N´,-Tetramethylethylendiamin) - Bio-Rad, USA 
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Visualization of protein bands was done by heating the gels in Coomassie Blue for 10 
minutes in the microwave and subsequent decolorization by heating in water several times 
until the bands demarcate. 
Coomassie Blue: Serva Blue G-250 0.025% 
 Acetic acid 10% 
 Ethanol 50% 
 
2.2.4 Preparative electrophoresis 
Electro elution was used for the exact purification of the proteins. Thus, protein was 
separated in a big preparative SDS gel and stained with Coomassie. The visualized bands 
were cut with a scalpel and brought into an electro elution chamber. The proteins were 
eluted at 100 V overnight in elution buffer (25 mM Tris, 192 mM glycine, 0.025% SDS). 
Electro elution chamber, S&S Biotrap - Schleicher&Schüll, Dassel 
Maxigel chamber, Protean IIxi Cell - Bio-Rad, USA 
 
2.2.5 Determination of protein content 
2.2.5.1 BCA (Bicinchoninic acid) assay 
40 µl of each protein probe was mixed with 400 µl BCA solution (BCA solution A:B = 
50:1) and incubated for 30 minutes at 60 °C. The same procedure was used with a 
standard row of BSA (bovine serum albumine, 0-200 µg/ml) in PBS. Afterwards 
extinctions were measured at 550 nm and the protein concentrations calculated from the 
standard values.  
BCA solution A: BCA-Dinatrium 25.8 mM 
 Na2CO3 160 mM 
 Na2-Tartrat 7 mM 
 NaOH 100 mM 
 NaHCO3 113 mM 
BCA solution B: CuSO4x5H2O 160 mM 
 
2.2.5.2 Bradford assay 
In a manner similar to that used with the BCA assay, a standard row and the protein 
solution were solved in 800 µl probe buffer and subsequently mixed with 200 µl 5 x 
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staining solution (Rotiquant). After 10 minutes the probes were measured at 595 nm in a 
photometer and the protein concentration calculated from the standard values. 
 
2.3 Raising of antibodies in rabbits 
2.3.1 Immunization and blood taking 
For each fusion protein two 4-5 months old “New Zealand white” rabbits were immunized 
with either 90 or 180 µg of the produced protein. Therefore, 500 µl or 1000 µl antigen 
were injected intracutaneously after shaving the injection sites. To increase the immune 
reaction the protein solutions was mixed with an adjuvant and two booster immunizations 
were performed after an interval of 3-4 weeks. 
Immunization solution: 
Complete Freund’s adjuvant (CFA) 1.25 ml Sigma, USA 
Antigen (360 µg) in PBS  750 µl 
 
Before the first injection a blood sample was taken (preimmune serum) and starting with 
day 35, 30 ml blood were taken weekly from the rabbit ear. The blood coagulated 
overnight at 4 °C and the separated serum was centrifuged at 2500 x g. The complement 
system was inactivated by heating for 1 hour at 56 °C and the sample was stored at –80°C. 
After 12 weeks the animals were killed by cervical dislocation and exsanguinated, the 
blood was processed as described above. 
 
2.3.2 Determination of antibody titer, ELISA 
Determination of antibody titer is mandatory to observe and follow the production of 
antibodies. The “enzyme-linked immunosorbent assay” (ELISA) is an adequate method. 
Micro titer plates are coated with antigen and subsequently incubated with the antibody 
whose concentration should be determined. A secondary antibody is added onto the plates 
after the washing process, and a staining reaction visualizes the amount of primary 
antibody. 
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Table 4: ELISA 
Procedure:    
Antigen coating 100 µl 1 µg/ml in coating buffer1 15 h 
Saturation of unspecific bindings 150 µl saturation solution2 pH 7.2 1 h 
Primary antibody (e.g. serum) 100 µl diluted in saturation solution 2 h 
Washing (3x) 200 µl PBS  
Secondary antibody 100 µl peroxidase-conjugated AB goat-anti-rabbit, 
1:1000 in 1mg/ml PBS-Hb 
 
Washing (3x) 200 µl PBS  
Visualization 100 µl incubation solution3 pH 4.2 5 min 
Stop 100 µl block solution (0.1% sodium azide)  
Measurement of extinctions at 450 nm   
  
1   50 mM Na2CO3 in water, pH 9.6   
2  50 mM NaH2PO4xH2O 3  50 mM NaH2PO4xH2O 
   150 mM NaCl 100 mM NaCH3CO2x3H2O 
   0.05% Tween 20 1 mg/ml ABTS 
   0.02% Sodium azide 0.88 mM H2O2 
   1 mg/ml Hemoglobin   
 
ELISA-Micro plate, Falcon3912 - Becton Dickinson, USA 
ELISA Photometer, Dynatech MR 5000 - Dynatech Laboratories, USA 
P-GaR  (goat anti rabbit antibody) - Vector, USA 
 
2.3.3 Competitive ELISA 
This special modification of ELISA is preceded by preincubation of the antibodies for 2 
hours with different antigens in varying concentrations (10 µg – 0.1 ng). The results 
indicate both the affinity of antibodies (decrease of extinctions, see Fig. 12) and the absent 
cross reactivity to other antigens. 
 
2.4 Purification of antibodies 
2.4.1 Removal of IgM 
For all experiments only antibodies of the immunglobuline class G (IgG) were used, 
because only this class can be detected with the secondary antibodies used. Furthermore, 
included antibodies of the IgM class would cause undesirable background in the 
immunohistochemical experiments. Therefore, IgM antibodies were removed using a 
Superdex-200 column: 2.5 ml rabbit serum from the fractions with the highest antibody 
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titer were pumped through the column. The bigger IgM molecules move faster through the 
porous agarose beads than the smaller IgG antibodies. The resulting fractions with the 
highest titer were detected due to their extinctions (Fig. 9) and pooled (circa 10 x 2 ml). 
Fraction collector FC 203 B - Abimed Gilson, USA 
Peristalsis pump Minipuls 3 - Abimed Gilson, USA 
Photometer 112, UV/VIS Detector - Abimed Gilson, USA 
Column Superdex 200 prep grade - Pharmacia Biotech, Sweden 
Writer BD 111 - Kipp & Zonen / Sci-Tec Instruments, Canada 
 
2.4.2 Removal of cross reactivity 
The IgM-purified serum was tested for cross reactivity to the fusion part of the 
immunization protein, to bacterial surfaces and to other Kir channels. In case of cross 
reactivity, the serum was incubated with the detected undesirable antigens. 
The antibodies to the fusion part55 and to bacterial structures were removed by applying a 
bacterial suspension (expression of bacteria with only the fusion part, centrifugation for 15 
minutes at 4000 g, treatment with 0.5 % formaldehyde and autoclave). The bacterial 
suspension was added to the 1:100 in PBS-Hb diluted serum, the amount having been 
determined in previous experiments (Fig. 10), incubated overnight at 4 °C and centrifuged 
for 15 minutes at 4000 g. The supernatant contains the wanted antibodies. 
After determination of cross reactivity to closely related Kir channels, these antibodies 
were removed. Therefore, nitrocellulose membranes were coated with the cross reacting 
antigen56 overnight (2-8 µg/ml in PBS, according to previous experiments). Free binding 
sites were then saturated with 5 % NGS (normal goat serum) in PBS for 3 hours and the 
membranes incubated with the serum. Thus, the desirable antibodies were able to bind. 
Finally, the supernatant was checked again for cross reactivity (Fig. 11) 
NGS, goat serum - PAN Systems, Aidenbach 
Nitrocellulose - Schleicher & Schuell, Dassel 
 
                                                 
55 POMPÉIA, C. 1996 
56 VEH, R.W. 1995 
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2.4.3 Affinity purification 
Affinity purification is performed in a manner similar to that used for removing of cross 
reactivity by coating nitrocellulose membranes with antigen overnight (2 µg/ml in PBS). 
Therefore, however, the second fusion protein57 was used which is the Kir channel 
fragment cloned into the pet32b vector (see table 3). The membranes were washed three 
times with PBS and unspecific bindings blocked with 5 % NGS in PBS for 1 hour, 
followed by incubation with the serum (1:100 in 5 % NGS) for 4 hours. The membranes 
were washed again three times with PBS and eluted for 30 minutes1. Finally, the elution 
was dialysed against 20 mM phosphate buffer (pH 6) overnight. 
1 Elution buffer (pH 2,5 with HCl) = Glycine 200 mM, NaCl 150 mM, BSA 1 mg/ml 
 
2.4.4 Chromatofocussing 
Determination of the isoelectric point of antibodies is mandatory for a pH dependent 
concentration of antibodies. Therefore, an anion exchange column (PBE-94 material) is 
used which separates different proteins according to their varying charge. The column was 
equilibrated above the expected isoelectric point with 10 ml loading buffer (25 mM 
Ethanolamine, pH 9.4) and loaded with 5 ml affinity purified antibody solution that was 
dialysed against loading buffer. The column was then rinsed with 10 ml loading buffer and 
eluted with 25 ml Polybuffer (pH 6.0). The elution was collected in 0.5 ml fractions. The 
pH of the fractions with the highest affinity to the antigen (ELISA) determined the 
isoelectric point of the antibodies. 
PBE 94, Polybuffer exchanger - Pharmacia, Schweden 
Polybuffer 96-CH3COOH - Pharmacia, Schweden 
 
2.4.5 Concentration of antibodies 
The antibody concentration was increased using a SP-Sepharose cation exchange column. 
The sulfopropyle groups of the sepharose material bind positively charged proteins above 
a pH of 2. The column was equilibrated with 20 ml loading buffer (20 mM phosphate 
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buffer, pH 6.0). The column was then loaded with affinity purified antibodies that are 
positively charged at pH 6. Finally, 200 µl-fractions were eluted with a basic buffer (200 
mM Na2CO3, pH 9.0) by detaching the antibodies due to the negative charge. The 
fractions were checked by ELISA for antibody titer and the richest were pooled and 
dialysed. 
SP-Sepharose Fast flow - Pharmacia, Schweden 
 
2.5 Characterization of antibodies 
2.5.1 Analysis of specificity in Western Blots 
2.5.1.1 Preparation of brain homogenates 
Brains were rapidly dissected from deeply anesthetized (ether) adult Wistar rats (5-9 
weeks) and rapidly frozen on dry ice. 2 ml of homogenization buffer were added per gram 
of rat brain and the solution was homogenized 10 times in a Dounce homogenizer. The 
homogenate was centrifuged at 4 °C for 10 minutes at 600 x g to remove cell debris and 
nuclei, and the supernatant was centrifuged at 100.000 x g for 10 minutes to pellet mem-
branes. The pellet which contains cell membranes and organelles was resuspended in 
homogenization buffer. 
Dounce homogenizer - Wheaton, USA 
 
Homogenization buffer  added before use:  
Saccharose 250 mM  Aprotinin 2 µg/ml 
Hepes; pH 7.4 4 mM  Pepstatin A 1 µg/ml 
EDTA 1 mM  Leupeptin 1 µg/ml 
Na-azide 5 mM  PMSF 0.5 mM 
 
2.5.1.2 Western Blotting 
Proteins were separated on an SDS gel and transferred to nitrocellulose membranes using 
the BioRad semidry blot device which is constructed as follows: 
• anode 
• 3 layers of 3 MM Whatman paper 
• nitrocellulose 
• SDS gel 
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• 3 layers of 3 MM Whatman paper 
• cathode 
 
The Whatman paper and the nitrocellulose were previously rinsed in semidry buffer. 
Blotting was performed at 300 mA / gel for 30 minutes. After transfer, the proteins were 
visualized on the membrane by using Ponceau S-solution. The nitrocellulose membranes 
were cut in strips containing single protein lanes and totally decolorized in PBS. 
 
Semidry buffer  Ponceau S-solution  
Tris 48 mM  trichloric acid 3% 
Glycine 390 mM  Ponceau S 400 mg/l 
SDS 0.04% (w/v)    
Methanol 20% (v/v)    
 
2.5.1.3 Immune detection 
The unspecific binding sites at the membranes were saturated using 5 % low-fat milk in 
PBS containing 0.1 % Tween-20 for 1 hour. The primary antibody solution (anti-Kir2.1 
[1:1000], anti-Kir2.2 [1:500], anti-Kir2.3 [1:500], anti-Kir2.4 [1:5000] in 5 % 
milk/PBS/0.1 % Tween-20) was added and incubated overnight at 4 °C. The blots were 
washed 5 times in PBS/0.1 % Tween-20 (1 hour in total) and the secondary antibody was 
added (1:500-1:1000 in PBS/0.1 % Tween-20) for 2-3 hours. Thereafter, the membranes 
were washed again 5 times in PBS/0.1 % Tween-20 and developed. 
 
2.5.1.4  Visualization by use of alkaline phosphatase (aP)  
The aP-conjugated secondary antibody was visualized using the substrate NBT/BCIP (Ni-
tro Blue Tetrazolium / 5-bromo-4-chloro-3-indolyl phosphate). 
Procedure: 
The blots were incubated in 10 ml aP-development solution for 2-25 minutes depending 
on visualization intensity. The reaction was stopped by washing with PBS. 
aP-development solution:  
Tris; pH 9.5 100 mM 
MgCl2 50 mM 
NaCl 150 mM 
added before use:  
NBT (75 mg/ml in 700 µl DMF + 300 µl H2O) 50 µl/10 ml 
BCIP (50 mg/ml in 1ml DMF) 37.5 µl/10 ml 
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2.5.2 Analysis of specificity by transfected cells 
2.5.2.1 Liposome-mediated transfection 
African green monkey COS-7 kidney cells were cultured at 5 % CO2 in Dulbeccos 
modified Eagle medium supplemented with 10 % fetal calf-serum on 6-well-dishes 
containing four glass plates. At 60 % confluence cells were transiently transfected using 
lipofectin-DNA solution and incubated for 6 hours. After adding serum-containing 
medium, cells were incubated for 48-72 hours at 37 °C. 
Production of lipofectin-DNA solution from solution A and B: 
Solution A: 1-2 µg DNA diluted in 100 µl serum free medium per transfection 
Solution B: 2-10 µl lipofectin were diluted in 100 µl SFM 
Both solution were incubated for 30-45 minutes at room temperature, mixed carefully and 
incubated for another 10-15 minutes at room temperature. The lipofectin-DNA solution 
was then used for transfection. 
lipofectin - Gibco Brl, Life Technologies, GB 
 
2.5.2.2 Detection of transfected cells by immunofluorescence  
Cells were washed in PBS followed by fixation in 4 % phosphate-buffered formaldehyde 
and three washing steps with PBS. After blocking for 1 hour at room temperature in 5 % 
normal goat serum (NGS) in PBS containing 2 % BSA and 0.3 % Triton-X-100, cells 
were incubated with the primary antibody for 2 h at 37 °C (in 5 % NGS/ 2 % BSA/ 0.3 % 
Triton). Subsequently, cells were washed 3 times in PBS, incubated with the secondary 
antibody (fluorescent Oregon Green 488-goat anti-rabbit IgG 1:200, diluted in PBS/ 2% 
BSA/ 0.3 % Triton) for 2 hours at room temperature and washed again with PBS. 
Coverslips were mounted with moviol 4-88 containing 2.5 % of 1,4-diazobicyclo-[2.2.2]-
octane as anti-fading substance and viewed using fluorescence microscopy at 488 nm. 
Oregon Green 488-goat anti-rabbit IgG 1:200 - Molecular Probes, USA 
moviol 4-88 - Hoechst, France 
1,4-diazobicyclo-[2.2.2]-octane - DABCO; Sigma, Munich 
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2.6 Immunocytochemistry 
2.6.1 Perfusion fixation of rat brains 
Adult Wistar rats were deeply anesthetized with ether, injected with muscle relaxant and 
coagulation inhibitor (ketamine, rompun and heparin adapted to body weight) and 
perfused transcardially with: 
• plasma substitute (Longasteril, Fresenius) for 10 seconds at 210 torr 
• PGPIC for 5 minutes at 210 torr 
• PGPIC for 25 minutes at 20 torr and 
• sucrose solution for 5 minutes. 
Brains were dissected out, embedded in 2 % agarose in sucrose solution, and cut 
transversely into 2-3 mm thick sections. Brains were cytoprotected in 10 % sucrose for 1 
hour and in 30 % sucrose overnight, frozen in hexane at –60 °C, attached to cork plates 
and stored at –80 °C until use. 
PGPIC (fixation solution), pH 7.4 sucrose solution, pH 7.4 
paraformaldehyde 4% (w/v)  sucrose 146 mM 
NaH2PO4xH2O 100 mM  NaH2PO4xH2O 100 mM 
glutaraldehyde 0.05% (w/v)    
picric acid 0.37%    
 
2.6.2 Rat brain slices for light microscopy 
For light microscopy, frozen brain blocks were cut into 20 µm cryosections on a 
microtome and rinsed several times in PBS. After treatment with 1 % sodium borohydride 
in PBS for 15 minutes to remove excessive aldehydes and two washing steps with PBS for 
15 minutes, sections were preincubated in 10 % NGS in PBS containing 0.3 % Triton-X-
100 and 0.05 % phenyl hydrazine to reduce the endogenous peroxidases. Sections were 
washed subsequently three times in PBS, followed by incubation for 36 h at 4 °C in the 
primary antibody solution (rabbit anti-Kir2.1 [1:400], anti-Kir2.2 [1:100], anti-Kir2.3 
[1:100], anti-Kir2.4 [1:5000] in 10 % NGS in PBS containing 0.3 % Triton-X-100, 0.1 % 
sodium azide and 0.01 % thimerosal). Sections were washed in PBS two times for 20 and 
40 min, preincubated for 1 h in PBS-A (2 mg BSA/ ml PBS) and incubated for 16 h at 
room temperature in the secondary antibody solution (biotinylated goat anti-rabbit IgG 
1:2000 in PBS-A containing 0.3 % Triton-X-100 and 0.1 % sodium azide). After two 
washing steps in PBS, preincubation for 1 hour in PBS-A and incubation in 1:1000 avidin-
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biotin-complex (10 µl Elite A dissolved in 10 ml PBS-A, 10 µl Elite B added) for 6 h at 
RT, sections were washed three times in PBS (10, 20 and 30 minutes), followed by a 
preincubation in DAB-solution (0.5 mg DAB in 1 ml 50 mM Tris-buffer, pH 7.6, 
containing 10 mM imidazole) for 15 min. Sections were visualized by adding ammonium 
nickel sulfate (0.3 % final concentration) and H2O2 (0.015 % final concentration) for 3 
min. Finally, they were washed several times in PBS, mounted onto gelatin-coated slides, 
dried for 30 minutes, dehydrated in increasing alcohol concentrations, brought into xylol, 
and coverslipped with entellan. In control experiments, the primary antibody was 
preabsorbed with 10 µg specific antigen per 1 ml antibody solution. 
Elite A (avidin) - Vector Laboratories, USA 
Elite B (biotinylated peroxidase) - Vector Laboratories, USA 
DAB solution (3,3-diaminobenzidine) - Sigma, Munich 
 
2.6.3 Rat brain slices for fluorescence microscopy 
For fluorescence microscopy, frozen brain blocks were cut into 20 µm cryosections on a 
microtome and rinsed in PBS. After treatment with 1 % sodium borohydride in PBS for 15 
minutes and two washing steps with PBS for 15 minutes, sections were incubated in 10 % 
NGS in PBS containing 0.3 % Triton-X-100 to saturate unspecific binding sites. Slices 
were incubated for 36 h at 4 °C in the primary antibody solution (rabbit anti-Kir2.4 
[1:5000] in 10 % NGS in PBS containing 0.3 % Triton-X-100, 0.1 % sodium azide and 
0.01 % thimerosal). Sections were washed in PBS two times for 20 and 40 min, 
preincubated for 1 h in PBS-A (2 mg BSA/ ml PBS) and incubated for 16 h at room 
temperature in the secondary antibody solution (fluorescent anti-rabbit IgG in PBS-A 
containing 0.3 % Triton-X-100 and 0.1 % sodium azide). Slices were washed again 3 
times in PBS and, finally, coverslipped with moviol 4-88. 
 
2.6.4 Coating of slides 
Glass slides were washed thoroughly (dishwasher), dived into warm gelatine solution for 
3 minutes and dried for 2-3 days at room temperature in a dust-free environment. 
Production of gelatine solution: 
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15 g gelatine and 1.76 g potassium chromosulfate-12-hydrate were diluted at 70 °C in 630 
ml H2O. 300 ml 100 % ethanol and 70 ml acetic acid were then added and the solution 
filtered. 
 
2.6.5 Cresyl violet staining 
Microtome sections were coated on glass slides, dried for 30 minutes and dehydrated in 70 
% ethanol overnight. The slides were washed for 2 minutes in H2O and stained in cresyl 
violet solution for 20-30 minutes. Afterwards, they were washed again for 2 minutes in 
H2O, dehydrated in increasing ethanol concentrations (70 %, 86 %, 96 %, 100 % I, 100% 
II for 5 minutes each), brought into xylol, and coverslipped with entellan. 
 
Cresyl violet solution 
 
cresyl violet acetate 0.2% (w/v) 
acetic acid 20 mM 
pH 4.0 with NaOH, always filter before use  
 
2.6.6 Electron microscopy 
2.6.6.1 Immunoreaction 
For electron microscopy, frozen brain blocks (stored at -80 °C) were thawed in 30 % 
sucrose in PBS. 40 µm slices were sectioned on a vibratome at 4 °C and rinsed several 
times in PBS. Sections were incubated with antibodies as in paragraph 2.6.2., with one 
exception: Triton-X-100 (0.1 % final concentration) was added only to the 0.05 % phenyl 
hydrazine preincubation solution. Sections were visualized for 10 min by adding 0.015 % 
H2O2 but omitting nickel ions.  
Composition of secondary antibody solution: 
biotinylated 2° AB 1:2000 in PBS-A with 0.1% Na-azide 
0.8 nm gold-labeled 2° AB 1:40 in PBS with 0.1% BSA-C; 0.1% Tween und 0.1% NaN3 
 
2.6.6.2 Staining with the avidin-biotin method 
After two washing steps in PBS and incubation for 1 hour in PBS-A, sections were 
incubated with the avidin-biotin complex for 6 hours at room temperature. Slices were 
washed three times in PBS (10, 20 and 30 minutes), followed by a preincubation in DAB-
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solution (0.5 mg DAB in 1 ml 50 mM Tris-buffer, pH 7.6, containing 10 mM imidazole) 
for 10-12 minutes. Sections were visualized by adding H2O2 (0.015 % final concentration) 
for 3 minutes (without ammonium nickel sulfate). After thoroughly washing in PBS, the 
tissue was embedded in araldite. 
 
2.6.6.3 Gold-silver-enhancement 
In the experiments in which a gold-labeled secondary antibody was used, the slices were 
washed 10, 20 and 30 minutes in PBS-Tween (0.05 % Tween 20), followed by a 15 
minutes fixation step in 2 % glutaraldehyde in PBS. After a short rinsing in PBS, the 
sections were washed 5 times in 150 mM NaNO3 solution and silver-enhanced in the dark 
for 25 minutes. The sections were washed a few times in PBS and fixed in 2 % 
glutaraldehyde for 10 minutes, rinsed again in PBS and subjected to the following araldite 
embedding. 
 
2.6.6.4 Araldite embedding 
Slices were post-fixed with 1 % osmium tetroxide in PBS for 15-30 minutes, washed in 
phosphate buffer (100 mM NaH2PO4xH2O; pH 7.4 with NaOH), dehydrated through 
graded ethanol and block stained with 2 % uranyl acetate in 70 % EtOH for 10 min at 4 
°C. The sections were dehydrated again in graded ethanol (3 x 70 % EtOH, 2 x 95 %, 3 x 
100 %), transported into propylene oxide twice for 5 minutes and incubated overnight in 
the propylene oxide/ araldite mixture. Afterwards, the slices were incubated 2 x 2 hours in 
the embedding solution and embedded in araldite between two sheets of Aclar plastic. The 
polymerization of the araldite was performed for 24-60 hours at 65 °C. Finally, the regions 
of interest were cut and glued to a carrier plastic. 
Ultrathin (60-80 nm) and semithin tissue sections (800-1000 nm) were cut alternately with 
a diamond knife and the ultrathin sections were collected on copper grids for electron 
microscopy.  
Aclar plastic - Ted Pella, USA 
Diatome diamond knife 
Araldite solution: Araldite and DDSA were intensively mixed in a ratio of 30:24. 
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Propylene oxide / araldite mixture: 55 g araldite solution was mixed with 1.5 ml DMP-30 
and 50 ml propylene oxide. 
Embedding solution: 100 g araldite solution was intensively mixed with 2 ml DMP30. 
 
2.6.6.5 Contrasting the ultrathin sections 
The sections were counterstained for 5 minutes with 5 % uranyl acetate in water, 
intensively washed in water, incubated for 5 minutes in lead citrate solution and washed 
again thoroughly in water. Thereafter the sections were examined with a transmission 
electron microscope. 
transmission electron microscope  - EM 900, Zeiss 
 
lead citrate solution  
lead citrate 1.33 g in 50 ml 
sodium citrate 1,76 g auf 50 ml 
pH 12.0 with NaOH   
 
2.6.6.6 Toluidin blue staining 
The semithin tissue sections were dried on glass slides and stained for 2-5 minutes in 
toluidin blue solution. They were then rinsed with H2O and and coverslipped with 
entellan.  
Toluidin blue solution; pH 9.35 
Na2B4O2 x 10H2O 1% (w/v) 
Toluidin blue 1% (w/v) 
sucrose 40% (w/v) 
 
2.6.7 Histological analysis 
 The nomenclature of Paxinos and Watson for the rat brain58 is used throughout this 
report to refer to anatomical structures. 
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3 Results 
3.1 Preparation of monospecific and affinity-purified antibodies 
3.1.1 Comparison of the amino acid sequences 
Functional Kir2 channels are formed by tetrameric association of subunits. Each subunit 
contains two membrane-spanning regions M1 and M2. They flank a highly conserved 
pore-forming loop called H5. In order to produce specific antibodies against individual 
members of the Kir2 family, unique amino acid segments are needed. Comparison of the 
complete sequences of the Kir2 subfamily (Fig. 7) shows strong homology between the 
members in the transmembrane domains, the pore region and the adjoining cytoplasmic 
amino acids (shaded red). The most significant differences exist at the carboxyl terminal 
regions, making them the best target for antibodies. These less conserved sequences (42-
68 amino acid residues, shaded gray in Fig. 7) were selected as fusion proteins for 
subsequent cloning and then for raising of polyclonal antibodies in rabbits. 
The selected sequences were also searched for homologies with other proteins using the 
protein databases Swiss-Prot, NCBI-BLAST and TrEMBL. The Kir2.3 sequence contains 
two known domains, namely the Poly-Glu domain in amino acid position 383-390 and the 
Poly-Ala domain in position 391-399. There were no such domains in the sequences of the 
Kir2.1, Kir2.2 and Kir2.4 protein, respectively. The Poly-Ala-Poly-Glu domain or closely 
related domains were found in human ALMS1 protein, microtubule-associated protein 
EB1 (Arabidopsis thaliana), human PEG3 protein, different zinc finger proteins, mouse 
growth factor receptor bound protein 2-associated protein 3, NBS-LRR-like protein 
(Oryza sativa), human KIAA1855 protein and human mixed lineage kinase. 
If there was a cross reaction to these proteins, we should detect a signal in non-transfected 
COS7 mammalian cells, as some of these proteins, the zinc finger domains in particular, 
are present in virtually all mammalian cells. However, the anti-Kir2.3 antibody only 
stained cells that were transfected with the Kir2.3 DNA while control cells remained 
unstained (not shown). This finding is confirmed by Western blots. Instead of multiple 
bands only a single band can be detected in the expected range of the Kir2.3 channel 
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protein (see Fig. 14). Thus, the affinity purified anti-Kir2.3 antibody does not detect 
certain domains in other proteins. 
 
Fig. 7: Amino acid sequences of Kir2 subfamily members. The primary structures of all rat Kir2 
channel subunits demonstrate that sequence conservation is lowest in the carboxyterminal area. 
Sequences shared by all four subfamily members are labeled in red. The carboxy terminal sequences 
uses for antibody production are depicted in gray. M1, M2 transmembrane regions; P5 pore-forming 
region (adapted from Töpert 1998) 
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3.1.2 Recombinant fusion proteins 
After PCR amplification, the carboxyl terminal regions were cloned into the procaryotic 
expression vectors pQE40 and pGEX-4T-1 applying restriction enzymes. After plasmid 
transformation, positive clones were selected and protein expression in E. coli bacteria 
was performed. Fig. 8 displays the purified fusion proteins that were used for rabbit 
injections in two animals with different doses. 
 
 
Fig. 8: SDS-PAGE of purified fusion proteins Kir2.1-Kir2.4 
 
3.1.3 Removal of IgM antibodies by gel-filtration 
Antibodies of the IgM class cannot be detected by applying further secondary anti-rabbit 
antibodies. However, they may reversibly block epitopes and prevent the binding of IgG 
antibodies, thereby decreasing the specific signal. Therefore these immunoglobulins need 
to be removed. Rabbit sera with the highest titer of specific Kir2 antibodies were pooled. 
Separation of IgG and IgM was performed by passage of the Superdex-column making 
use of the wide difference in molecular weight. The example of the Kir2.2 antibodies (Fig. 
9) demonstrates the procedure of fraction selection: The protein line measured 
photometrically at 280nm (green line) displays the large IgM in the first peak (fractions 
20-24). An ELISA measurement of the immunoreactivity to the Kir2.2 antigen (red line) 
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leads to the fractions with highest IgG concentration. Fractions 24-36 were pooled and 
used for further purification of specific antibodies and as a control of cross reactivities 
among the Kir family. An analogous procedure was used with remaining Kir2 subfamily 
members.  
 
 
Fig. 9: Elution profile after passage through a superdex column. The green line represents the protein 
concentration and the red line the immunoreactivity to the corresponding Kir2 protein. Fractions 
selected on the basis of high antibody titer (24-36) are marked. 
 
3.1.4 Affinity purification 
The remaining solution contains antibodies specific to the Kir2 channel protein, but of 
course also to the rest of the fusion protein. Therefore absorption of these unintended 
antibodies was achieved by applying pQE40 or pGEX protein as the next step of 
purification. The optimal amount of protein was determined by testing the decreased cross 
reactivity depending on added protein concentration (Fig. 10A, arrow). Moreover, to get 
the anti-Kir2 antibodies, solely affinity purification was performed making use of a 
second expression system (pet32b); hence a different protein pattern surrounding the 
antigenic sequence. Nitrocellulose membranes were coated with this new fusion protein. 
Hence only antibodies to the Kir2 protein could bind and subsequently become washed 
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out (compare 
methods).
 
Fig. 10: Affinity purification. A) Initial application of pQE40 protein only to absorb cross reactivity to 
the plasmid part of the expressed antigen. B) Varying conditions to find protein concentration with 
best antibody quantity. 
 
Previously, optimal conditions for affinity purification were tested to find an effective 
ratio between applied antigen amount and purified antibody concentration. Exemplary in 
the case of Kir2.2 (Fig. 10B) the highest amount of antibodies was collected using 5 µg 
protein/ cm2 (arrowhead). Nevertheless only about 25% of starting activity was detectable, 
probably because of a high antibody affinity for the protein tethered to the membrane. 
Even more radical elution conditions (decreased pH) could not increase the quantity of 
purified antibodies. The sera of the remaining Kir2 proteins were processed using the 
same method and parameters. 
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3.2 Specificity of purified antibodies 
3.2.1 Cross reactivity 
Prior to affinity purification, immunoreactivity is present to the common part of the fusion 
protein. Afterwards all four anti-Kir2 antibodies failed to show any cross reactivity to the 
other subfamily members. Additionally, cross-reactivity concerning the related Kir3 
subfamily was excluded (Fig. 11). 
 
Fig. 11: No cross reactivity to other Kir subunits. Microtiter plates were coated with different 
proteins of Kir channels. Antibodies of the Kir2 subfamily exclusively detect their corresponding 
antigen and display no cross reactivity to other subunits. The horizontal line indicates extinction of 
BSA controls. 
 
 
3.2.2 Competitive ELISA 
Antibody quality was evaluated at several further levels following affinity purification. 
Specificity for the corresponding primary sequences is shown best in the competitive 
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ELISA assay (Fig. 12). It shows on the one hand that a specific polyclonal antibody 
cannot be blocked by proteins of other Kir2 subfamily members, on the other hand that 
only the distinctive protein is able to reduce the immunoreactivity depending on the 
concentration used. This knowledge of specific recognition of native proteins is essential 
for antibody application to rat brain tissue sections. 
 
 
Fig. 12: ELISA assays of all members of the Kir2 subfamily. Microtiter plates were coated with the 
respective recombinant protein. Preincubation of antibodies with the cognate antigen only decreases 
the immunoreactivity in a concentration-dependent manner. Preincubation with other antigens did 
not show any effect. 
 
3.2.3 Western blot of fusion proteins 
A detection of denaturated fusion proteins was verified in Western blots supporting the 
results from the competitive ELISA. Reaction to all members of the Kir2 subfamily was 
examined. Again each antibody recognizes its corresponding antigen only (Fig. 13).  
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Fig. 13: Specificity of anti-Kir2 antibodies. In Western blots Kir2 antibodies recognize only their 
corresponding fusion protein and none of the other Kir2 subfamily members. 
 
3.2.4 Western blot of rat brain homogenates 
Competitive ELISA testing does not exclude cross reactivities with other cellular proteins. 
Therefore, the next step of specificity can be investigated by performing Western blot 
analysis of rat brain homogenates (Fig. 14). Only a single band in brain proteins suggests 
detection of the correct channel and the band is supposed to be located in the range of the 
expected molecular weight of the channel protein. All of the purified antibodies detect a 
specific band (left lane) that can be blocked by preincubation of the antibody with their 
fusion protein (right lane). In the case of Kir2.1, Kir2.2 and Kir2.3, the recognized protein 
displays the expected molecular weight as predicted from amino acid sequences. 
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Unfortunately, convincing Western blots from brain homogenates were not obtained with 
the anti-Kir2.4 antibodies that detect a single band with a molecular weight much higher 
than expected (see next paragraph). 
 
 
Fig. 14: Specificities of the anti-Kir2 antibodies as judged from Western blots. Homogenates from 
total rat brain membranes (10 µg/lane) were separated on 10% SDS-PAGE. All antibodies recognized 
single bands of the expected molecular weights (left lanes; with exception of Kir2.4, see next chapter) 
which were largely abolished subsequent to preincubation block with the cognate recombinant 
proteins (right lanes). 
 
3.2.5 Specificity of anti-Kir2.4 antibodies 
The surprising difference between the sizes of predicted protein versus obtained band with 
anti-Kir2.4 antibodies in western blot of rat brain homogenates (Fig. 14) required 
supplementary examination.  
In order to verify the specificity of the anti-Kir2.4 antibodies, COS-7 cells were 
transiently transfected with Kir2.4-DNA (Fig. 15A). In contrast to untreated controls (Fig. 
15B), incubation of transfected cells with anti-Kir2.4 antibodies visualized a remarkable 
fraction of positive cell bodies. Consequently, these antibodies recognize the correct 
antigen. To confirm the finding, a Western blot of homogenate of transfected cells was 
performed (Fig. 15C): only COS cells expressing the Kir2.4 channel display a protein 
band of predicted size (left lane), whereas no band is seen when blotting non-transfected 
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cells (right lane). Whether the fainter second band represents a phosphorylated form or a 
minor breakdown product remains unclear at present. 
So far, there are different possibilities causing the single band in the Western blot of exact 
double the size of the potassium channel monomer. On the one hand the antibody might 
cross-react with a yet unknown brain specific protein. On the other hand the band may 
represent a Kir2.4 dimer that did not further dissociate during SDS-treatment before the 
Western blot (see also discussion in chapter 4.1.). Further examinations are required to 
finally rule out cross-reactivity. 
 
 
Fig. 15A,B: Specificity of anti-Kir2.4 antibodies, transfection experiments. The specificity of the 
Kir2.4 antibodies was further verified by the immunofluorescence obtained with Kir2.4 transfected 
COS-7 cells (A). Non-transfected cells were negative (B). 
 
Since the Kir2.4 channel was reported to be expressed in the heart, an additional Western 
blot analysis of heart homogenate was done. It shows a protein band within the correct 
range (Fig. 15D), thus the anti-Kir2.4 antibodies recognize the correct protein size again. 
It is of remarkable interest that the Kir2.4 channel can be found only in neuronal structures 
of the heart59. 
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Fig. 15C,D: Specificity of anti-Kir2.4 antibodies. Western blots from transfected cells (C) displayed a 
double band (left lane), most probably due to the presence of phosphorylated species, within the 
expected range of molecular weights. Untransfected cells yielded blank blots (C, right lane). Western 
blots of heart homogenate (D) also show a protein band within the correct range. 
 
3.2.6 Antibody specificity in brain sections 
Immunocytochemical specificity was demonstrated using the olfactory bulb as an example 
(Fig. 16). The anti-Kir2 antibodies were applied to 20 µm rat brain sections. Each 
antibody showed a characteristic and individual distribution pattern. In all cases staining 
was abolished subsequent to preincubation with the cognate recombinant protein (not 
shown here, but see Fig. 23C). Chosen concentrations were used in all of the light 
microscopic screening experiments. 
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Fig. 16: Immunocytochemical labeling of the rat olfactory bulb confirms the specificity of the anti-
Kir2 antibodies. For detailed analysis of the immunocytochemical specificities of the anti-Kir2 
antibodies an area (boxed in A) containing the outer layers of the olfactory bulb was selected. 
Individual layers are evident at higher magnification in the section stained with cresyl violet (B). 
Immunoreactivities of individual members of the Kir2 subfamily (C-F) display specific and individual 
distribution patterns. Gl, glomerular layer; EPl, external plexiform layer; Mi, mitral cell layer; IPl, 
internal plexiform layer; Gr, granule cell layer. 
 
The immunocytochemical localizations of the Kir channel proteins were in good 
agreement with in situ hybridization data60. Thus, Kir2.1 immunostaining was most 
prominent in the glomerular layer (Fig. 16C), where also Kir2.1 mRNA is intensively 
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expressed61. Again in agreement with mRNA findings, Kir2.2 immunoreactivity was most 
prominent in the glomerular layer and only weakly detectable in the mitral cell layer. 
Contrasting the other subfamily members, Kir2.3 channel proteins were predominantly 
expressed in the external plexiform layer of olfactory bulb and were virtually absent from 
the periglomerular cells (Fig. 16E). This is in perfect agreement with recent data from 
Kurachi’s group62. Kir2.4 staining was found in most neurons, especially in the large cell 
bodies of mitral and tufted cells. Interestingly, in the granule cell layer, prominent 
immunostaining was displayed only by a small subset of granular cells (Fig. 16F, arrows). 
 
3.3 Distribution of Kir2 channels in the rat brain 
The expression of Kir2 mRNAs in the rat brain is known from in situ hybridization (ISH) 
experiments63. The corresponding proteins, however, may not necessarily be found in the 
same area, but may instead be sorted to the axons or their distant terminals. ISH data, 
therefore, do not necessarily display the subcellular and regional distribution of the 
channel protein and require complementary information from immunocytochemical 
experiments. Consequently, in a first step our experimental work focused on the general 
distribution of Kir2 channel proteins in different brain regions (Fig. 17-I – 17-IX). 
 
3.3.1 Olfactory system 
All four Kir2 subunits were expressed in the olfactory bulb (see detailed findings in 
chapter 3.2.6. and Fig. 16). Although all channels were expressed in the piriform cortex, 
the olfactory tubercle (Fig. 17-I) was labeled prominently by Kir2.1 and Kir2.3 antibodies 
and to a lesser extent by the other channel proteins. This finding is in excellent agreement 
with former data from in situ hybridization experiments64. 
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Fig. 17-I: Olfactory tubercle. For details see text. cc, corpus callosum; IG, induseum griseum; CPu, 
caudate putamen; AcbC, core part of the accumbens nucleus, AcbSh, shell part of the accumbens 
nucleus; Tu, olfactory tubercle; Pir, piriform cortex. 
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3.3.2 Hippocampus 
The most prominent Kir2 channel expression was detected in the dentate gyrus (Fig. 17-
II), although the Kir2.4 subunit was labeled to a lesser extent. Nevertheless, staining 
intensities varied also among the Kir2.1-2.3 members. Kir2.1 was present in the granule 
cell layer with particularly elevated levels, whereas the specific signal in all other 
hippocampal layers was very low, also including the neurons of the Ammon’s horn. In 
contrast, the Kir2.2 subunit was found to be markedly elevated in the molecular layer of 
the dentate gyrus. Although all four Kir2 subunits were virtually absent from CA3 
neurons, a prominent labeling of CA1 and CA2 neurons was detectable by Kir2.2 and 
Kir2.3 antibodies. Again the Kir2 channel distribution within the hippocampus is in good 
conformity with former in situ hybridization experiments65. 
 
3.3.3 Neocortex 
Kir2.1-2.4 channels were expressed in all cortical areas (Fig. 17-III,B-E) and the antibody 
signal could be seen in most of the cortical cells, suggesting a possible co-expression of 
the different Kir2 channels. The labeling pattern reflects the laminar structure of the rat 
neocortex when compared with a Klüver-Barrera-stained section (Fig. 17-III,A). The 
strongest immunoreactivity was shown by Kir2.1 and Kir2.3 with a focal point on layer II 
and III neurons. Kir2.2 protein was present at moderate levels in all layers, with 
particularly elevated levels in layer V pyramidal cells. The Kir2.4 subunit was expressed 
in virtually all cortical neurons, but with only weak immunoreactivity. This latter finding 
partly differs from the distribution pattern described by Töpert66, who reported the Kir2.4 
subunit to be absent from the rat cortex (see also discussion). 
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Fig. 17-II: Hippocampus. Areas C-F are boxed ‘a’ in A. For details see text. CA1-CA3, cornu 
ammonis 1-3; DG, dentate gyrus; fi, fimbriae; MHb, medial habenula; LHb lateral habenula. 
 
 RESULTS 58 
 
Fig. 17-III: Cortex (A-E), habenula (F-J). Areas A-E are boxed ‘b’ and F-J corresponds to ‘c’ in Fig. 
17-IIA. For details see text. 
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Fig. 17-IV: Nucleus accumbens. For details see text. cc, corpus callosum; CPu, caudate putamen; 
AcbC, core part of the accumbens nucleus, AcbSh, shell part of the accumbens nucleus; Tu, olfactory 
tubercle; Pir, piriform cortex; aca, anterior commissure. 
 
3.3.4 Basal ganglia and amygdala 
The caudate putamen and nucleus accumbens (Fig. 17-IV) were reported to be among the 
most prominently labeled brain structures when probed with Kir2.1 and Kir2.3 mRNAs67, 
which is in good agreement with our antibody studies (the differential channel distribution 
in the striatum is summarized in chapter 3.4.1.).  
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Fig. 17-V: Thalamus. For details see text. Areas G and H are boxed in A. CPu, caudate putamen; GP, 
globus pallidus; ic, internal capsule; Rt, reticular nucleus; sm, stria medullaris; Pir, piriform cortex; 
LOT, lateral olfactory tract nucleus; SO, supraoptic nucleus; ox, optic chiasma. 
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Kir2.4 was only weakly detectable in the nucleus accumbens, whereas all the other Kir2 
channel subunits were abundantly expressed. Kir2.1 and Kir2.2 proteins were present in 
all accumbal parts at moderate levels, whereas a more differential signal was observed for 
Kir2.3, with particularly elevated levels in the shell part of the nucleus accumbens (Fig. 
17-IV,E) and a patchy distribution resembling the expression pattern within the striatum 
(compare chapter 3.4.1.). Although Kir2.2-2.4 proteins were absent in amygdala nuclei 
and lateral olfactory tract nucleus, significant levels of Kir2.1 were found in the amygdala 
and strong Kir2.1 expression in the lateral olfactory tract nucleus (Fig. 17-V,C). 
 
3.3.5 Thalamus 
In the thalamus, all four Kir2 subunits displayed a differential distribution pattern. The 
Kir2.4 subunit was virtually absent in all thalamic nuclei. The Kir2.3 protein was also not 
detectable in most of the nuclei (anterior, lateral, paraventricular, posterior, medio-, 
laterodorsal, medial geniculate etc.), but it was expressed in the reticular thalamic nucleus 
(Fig. 17-V,E), which supports former mRNA studies68. The distribution of the Kir2.1 
channel subunit, however, is in contrast to these in situ hybridization experiments, where 
the Kir2.1 protein is reported to be absent from all thalamic nuclei. The present study 
reveals a strong signal in the anterodorsal nucleus (Fig. 17-V,C) and still moderate levels 
for example in anteroventral, reticular and  posterior thalamic nuclei. As previously 
described, the Kir2.2 subunit was abundant in many thalamic nuclei. 
 
3.3.6 Hypothalamus and habenula 
In conformity with earlier mRNA labeling69, the Kir2.2 channel subunit was expressed 
most prominently in hypothalamic nuclei with the highest signal being observed in 
anterior area, preoptic nucleus and supraoptic nucleus (Fig. 17-V,G). The Kir2.3 protein 
was absent in the hypothalamus and only weak expression was observed with Kir2.4 and 
Kir2.1 antibodies. The exception was the Kir2.4 immunoreactivity in the supraoptic 
nucleus, where particularly elevated levels were found. Only one subunit, Kir2.2, was 
present at extremely high levels in the medial habenula, but not in the lateral habenula 
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(Fig. 17-III,H). Kir2.1 protein was found throughout the habenula, but with significantly 
lower levels when compared with Kir2.2. In contrast, the Kir2.4 channel subunit was 
absent and the Kir2.3 protein was only weakly expressed in the medial habenula. 
 
 
Fig. 17-VI: Substantia nigra. For details see text. MG, medial geniculate; CG, central gray; SNC, 
substantia nigra pars compacta; SNR, substantia nigra pars reticulata; cp, cerebral peduncle; IP, 
interpeduncular nucleus. 
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3.3.7 Substantia nigra, ventral tegmental area (VTA), superior colliculus 
All four Kir2 channel subunits were expressed by substantia nigra cells in a differential 
pattern (Fig. 17-VI). The Kir2.1 and Kir2.4 subunit was observed only in the SN pars 
compacta, whereas the Kir2.2 and Kir2.3 proteins were expressed in both parts auf SN 
with markedly elevated levels in the pars reticulate, Kir2.2 and Kir2.3 displaying a similar 
distribution pattern, indicating co-expression of these two subunits. Only one channel 
protein, Kir2.1, was present at low levels in the ventral tegmental area. 
The superior colliculus (optic tectum) was among the most prominently labeled brain 
structures when labeled with Kir2.1 antibodies (Fig. 17-VII,C) and displayed also elevated 
signals for the Kir2.2 subunit protein. In contrast, the Kir2.3 subunit was only weakly 
expressed in this major target for retinal ganglion cells and the Kir2.4 channel protein was 
absent. Expression in the central gray was generally weak; however, few cells were 
expressing elevated levels of Kir2.2 protein. Otherwise, Kir2.2 and in this isolated case 
Kir2.4 channels were extensively expressed in the oculomotor nucleus (Fig. 17-VII,H/J), 
which is in line with with mRNA studies70. 
 
3.3.8 Cerebellum and spinal medulla 
The Kir2 channel proteins present remarkable differences in the expression pattern 
throughout the cerebellum (Fig. 17-VIII). The Kir2.2 subunit expression was the strongest 
in the cerebellar cortex with restriction to the granule cell layer, thereby supporting the 
former data from in situ hybridization71. Contrasting this previously reported mRNA 
distribution, the Kir2.3 channel protein was entensively expressed by the large neurons in 
the deep cerebellar nuclei and by Purkinje cells, which is, however, in agreement with 
data from Falk’s group72. The molecular layer contained low levels of Kir2.1 and Kir2.4 
proteins. Both channels were also weakly expressed in the deep nuclei of the cerebellum. 
All Kir2 subunits were present in the motoneurons of the spinal cord with particularly 
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elevated levels of the Kir2.2 channel protein. 
  
Fig. 17-VII: Mesencephalon. Adjacent sections of the oculomotor nucleus (G-J) are from the region 
boxed in A. For details see text. MG, medial geniculate; SuC, superior colliculus; CG, central gray; 
SNC, substantia nigra pars compacta; SNR, substantia nigra pars reticulata; VTA, ventral tegmental 
area; cp, cerebral peduncle; IP, interpeduncular nucleus; 3, oculomotor nucleus. 
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Fig. 17-VIII: Cerebellum. Adjacent sections from the cerebellar cortex (C-F) and deep nuclei (G-J). 
For details see text. Med, medial cerebellar nucleus; Int, interposed cerebellar nucleus; Lat, lateral 
cerebellar nucleus. 
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Fig. 17-IX: Medulla spinalis. For details see text. cu, cuneate fasciculus; lfu, lateral funiculus; vfu, 
ventral funiculus; 2-9, spinal cord layers. 
 
The previously reported preference of hindbrain structures to express the Kir2.2 subunit73 
can be supported by the finding of Kir2.2 protein throughout the gray matter of the spinal 
cord with extremely high levels in the substantia gelatinosa. 
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Table 5: Distribution of individual Kir2 subunits in different brain regions 
Brain region Kir2.1 Kir2.2 Kir2.3 Kir2.4 
 
Telencephalon 
    
Olfactory bulb     
    Glomerular layer ++++ + 0 + 
    External plexiform layer + 0 ++++ 0 
    Mitral cell layer + + + ++ 
    Granule cell layer ++ 0 + + 
Olfactory tubercle ++ + +++ 0 
Islands of Calleja + 0 0 0 
Piriform cortex ++ + ++ + 
Neocortex     
    Layer I 0 + + 0 
    Layer II +++ ++ +++ ++ 
    Layer III +++ ++ +++ + 
    Layer IV ++ + ++ ++ 
    Layer V ++ +++ ++ ++ 
    Layer VI ++ + + + 
Hippocampus     
    Dentate gyrus     
        Molecular layer + +++ + 0 
        Granule cell layer, Lamina sup. +++ ++ ++ + 
        Granule cell layer, Lamina inf. 0 + + 0 
        Polymorphic layer     
    CA1-CA2     
        Oriens layer 0 + ++ + 
        Pyramidal cell layer + ++ ++ + 
        Radiate layer 0 + ++ 0 
        Lacunosum moleculare layer + ++ + 0 
    CA3     
        Oriens layer 0 + + + 
        Pyramidal cell layer + + + + 
        Radiate layer 0 + + + 
Basal forebrain     
    Substantia innominata 0 + 0 + 
    Basal nucleus of Meynert + ++ ++ + 
Basal ganglia     
    Caudate putamen (Striatum) ++ +++ +++ + 
    Nucleus accumbens ++ ++ ++ + 
    Globus pallidus + ++ ++ + 
    Claustrum 0 + 0 + 
    Endopiriform nucleus + + + + 
Lateral olfactory tract nucleus +++ 0 + + 
Amygdala     
    Cortical nuclei + 0 0 0 
    Medial nucleus + 0 0 0 
    Basomedial nucleus + 0 0 0 
     
Diencephalon     
Thalamus     
    Anterodorsal nucleus +++ 0 0 0 
    Anteroventral nucleus ++ 0 0 0 
    Anteromedial nucleus + 0 0 0 
    Laterodorsal nucleus  + + 0 0 
    Mediodorsal nucleus  + 0 0 0 
    Centrolateral nucleus  0 ++ 0 + 
    Paraventricular nucleus  + ++ 0 + 
    Reuniens nucleus + + 0 0 
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    Reticular nucleus ++ ++ ++ + 
    Posterior nucleus ++ + 0 0 
    Medial geniculate nucleus + + 0 0 
    Paratenial nucleus + ++ 0 + 
Hypothalamus     
    Anterior area + ++ 0 + 
    Ventrolateral nucleus 0 + 0 + 
    Lateral area + + 0 0 
    Preoptic nucleus + ++ 0 + 
    Periventricular nucleus + + 0 0 
    Paraventricular nucleus + + 0 + 
    Supraoptic nucleus + ++ 0 ++ 
Epithalamus     
    Medial habenula ++ ++++ + 0 
    Lateral habenula + + 0 0 
     
Mesencephalon     
Red nucleus 0 + + + 
Substantia nigra     
    Pars compacta + ++ + + 
    Pars reticulata 0 +++ ++ 0 
Ventral tegmental area + 0 0 0 
Interpeduncular nucleus ++ +++ ++ 0 
Superior colliculus ++++ ++ + 0 
Central gray + ++ 0 + 
Edinger-Westphal nucleus + + 0 + 
Oculomotor nucleus (III) + ++ 0 +++ 
     
Metencephalon     
Cerebellum     
    Deep nuclei + 0 +++ + 
    Molecular layer + 0 0 + 
    Granule cell layer 0 +++ 0 + 
    Purkinje cells 0 0 ++ 0 
     
Myelencephalon     
Spinal medulla     
    Substantia gelatinosa + ++++ + 0 
    Motoneurons ++ +++ + + 
 
 
3.4 Distribution of Kir2 channels in the striatum 
The striatum plays a critical role in movement selection, motivated behavior and neural 
transmission via basal ganglia circuitry. To evaluate the possible involvement of Kir2 
channels in the fine tuning of these pathways, it is important to know their exact 
distribution within the striatum. A distinct localization in either the patch compartment or 
the cholinergic interneuron would suggest that selective channel activation or inhibition 
could specifically influence the outcome of a movement and, perhaps, open new strategies 
for novel therapeutic regimes.  
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Table 6: Striatal Kir2 channel expression, results from in situ hybridization experiments 
channel subunit author remarks 
Kir2.1 Karschin, C. et al. 1996 abundant (Acb, CPu) 
Kir2.2 Karschin, C. et al. 1996 moderate (Acb, CPu), large cells prominent
Kir2.3 Karschin, C. et al. 1996 abundant (Acb, CPu) 
 Falk, T. et al. 1995 only few (VP, CPu) 
 Bredt, D.S. et al. 1995 high (striatum) 
Kir2.4 Töpert, C. et al. 1998 no expression 
Abbreviations: Acb accumbens nucleus, CPu caudate putamen, VP ventral pallidum 
 
3.4.1 Kir2 subunits are differentially distributed in the rat striatum 
The expression of Kir2 mRNAs in the rat striatum is known from in situ hybridization 
experiments (table 5). Immunocytochemical experiments were performed to get more 
detailed information about the subcellular and regional Kir2 channel protein distribution.  
Rat brain sections were stained with antibodies to all four Kir2 subunits using the routine 
conditions described above. Although distribution in some regions of the rat brain is very 
divergent, in the striatum there are remarkable similarities: Survey micrographs (Fig. 18) 
suggest that all four Kir2 channel proteins are expressed by medium-sized spiny neurons. 
Nevertheless, staining intensities varied among the members of the potassium channel 
subfamily. The strong Kir2.2 staining of the neuropil in the caudatoputamen (CPu) 
obscured the visualization of neuronal cell bodies (Fig. 18D). Indeed, many spiny 
projection neurons were moderately labeled with no obvious preference for a subset of 
cells. Interestingly, neurons with prominent Kir2.2-immunoreactivity (Fig. 18D, 
arrowheads) were grouped in the pallidum (GP). The same was true for the Kir2.3 channel 
(Fig. 18E). Not all neurons of the pallidum are stained with the same intensity, suggesting 
functional differences. Whether the strongly stained neurons represent a cell type similar 
to the newly described type II neurons in the internal pallidum74 is unclear at present. 
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Fig. 18: Regional and cellular distribution of Kir2 subunits in the rat striatum. A series of six adjacent 
sections was used to analyze the immunocytochemical patterns of the individual members of the Kir2 
family. Coronal sections were obtained shortly caudal to the optic chiasm and stained according to 
Klüver-Barrera for morphological examination (A,B). An area (boxed in A) containing parts of the 
caudate-putamen and the external pallidum was selected for further investigation. Distinct patterns of 
immunostaining were obtained for the individual Kir2 subunits (C-F). Note that Kir2.2-positive 
neurons are clustered in the pallidum (D, arrowheads) and that large neurons in the striatum display 
prominent staining (F, arrows) with the anti-Kir2.4 antibody. CPu, caudate-putamen; GP, globus 
pallidum externum; Pir, piriform cortex; sm, stria medullaris thalami. 
 
The Kir2.1 subunit is apparently restricted to the somatodendritic compartment of many, if 
not all, spiny projection neurons leaving the neuropil unstained (Fig. 18C). Neurons of the 
pallidum also displayed homogeneous immunoreactivities. The Kir2.3 distribution pattern 
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of the caudatoputamen resembles that of the Kir2.1 subunit. Many projection neurons are 
labeled. In contrast to the other subunits, however, Kir2.3 immunoreactivity displayed 
stronger and weaker stained areas (see below). Finally, the Kir2.4 channel subunit showed 
a unique staining pattern with considerably less immunoreactivity as compared to the 
other Kir2 proteins (Fig. 18F). Probably all striatal and pallidal neurons could be detected 
with the anti-Kir2.4 antibodies. Some large neurons of the caudatoputamen, however, 
displayed especially strong Kir2.4 immunoreactivity (arrows). 
 
3.4.2 Anti-Kir2.2 antibodies stain striatal fiber bundles 
Aside from somatodendritic labeling of projection neurons, Kir2.2 immunoreactivity also 
produced a dense signal in the neuropil (Fig. 18). Under routine conditions (see methods) 
brain sections incubated with anti-Kir2.2 antibodies did not allow visual identification of 
stained fibers. However, a different image appeared when immunocytochemical 
conditions were optimized to focus on this special problem (Fig. 19). The lower 
concentration of anti-Kir2.2 antibodies hardly stained spiny projection neurons, but 
showed an extensive labeling of striatal fiber bundles, which was absent after 
preincubation with the Kir2.2 protein. This observation was consistent throughout rostral 
and caudal areas of the striatum and also in different animals. As an example, coronary 
sections of the striatum at the level of the anterior commissure (Fig. 19A, B) are depicted. 
The sorting of the Kir2.2 protein to the axon compartment is supported by data obtained at 
the electron microscopic level. Gold dots represent Kir2.2 channel protein. They are 
highly concentrated within the fiber bundle (Fig. 19C), but only sparse in the surrounding 
neuropil. 
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Fig. 19: Anti-Kir2.2 antibodies stain striatal fiber bundles. Using carefully selected conditions (for 
details see text) Kir2.2 immunoreactivity displayed a prominent labeling of fiber bundles within the 
striatum (A,B). At the electron microscopic level (C) the gold dots representing Kir2.2 channel 
distribution are found highly concentrated within the fiber bundles, suggesting the Kir2.2 subunit 
being sorted to the axonal membrane. Gold dots are sparse in the surrounding neuropil. 
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3.4.3 Kir2.3 channels are predominantly localized in the matrix 
compartment 
The detailed analysis of the Kir2.3 protein distribution again required carefully selected 
antibody concentrations. These optimized conditions demonstrate that from the Kir2 
family proteins only the Kir2.3 subunit is distributed inhomogeneously. Regions of low 
antibody binding are intermingled with areas of stronger immunoreactivity (Fig. 20A). 
This heterogeneity, which may be related to the compartmental organization, was 
detectable in all rats and extended throughout the whole striatum along the rostro-caudal 
axis.  
 
Fig. 20: Kir2.3 channel subunit protein is inhomogeneously distributed throughout the striatum. 
Complete immunostained sections (A) of the rat forebrain, unlike sections with antigen competition 
(B), show Kir2.3 immunoreactivity in the striatum. Using selected conditions, an inhomogeneous 
distribution of the Kir2.3 subunit in the striatum becomes obvious (C). The pattern of reduced Kir2.3 
staining seems similar to that of the striatal patch compartment as visualized via the 
immunocytochemical localization of µ-opiate receptors (D). 
 
Now one could argue that the patchy distribution of Kir2.3 immunoreactivity might be 
caused by the existence of cell-dense and cell-poor regions. To rule out this possibility the 
Kir2.3 localization was compared to an adjacent Klüver-Barrera stained section (Fig. 21). 
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The medium spiny neurons are rather homogeneously distributed between the prominent 
fiber bundles, a typical feature of the striatum. In regions of strong Kir2.3 reaction (Fig. 
21A and B, arrowheads) and in poorly stained areas (arrows), cell density is similar. 
Consequently, the patchy distribution of Kir2.3 channel subunits cannot result from high 
or low cell densities. In contrast, it seemed to be roughly congruent with the distribution 
of µ-opiate receptors (Fig. 20D), the original75 and well recognized marker of the striatal 
patch compartment.  
 
 
 
Fig. 21: Striatal cell density. Adjacent sections stained according to Klüver-Barrera (A) and for the 
Kir2.3 subunit (B) demonstrate that the increased Kir2.3 immunoreactivity is not simply due to an 
increased density of nerve cells at this location (compare areas between the three arrowheads or 
between the four arrows). Note the identical localization of capillaries in (A) and (B). 
 
The identity of the Kir2.3-weak areas with the patch compartment became obvious when 
both distribution patterns were compared in adjacent sections (Fig. 22). The upper images 
(Figs. 22A, C) display the distribution of patch compartments using immunocytochemical 
visualization of µ-opiate receptor distribution. The same areas in an adjacent section are 
shown in the lower panel photographs (Figs. 22B, D) stained with anti-Kir2.3 antibodies. 
Striatal fiber bundles are hatched to make sure that the patchy Kir2.3 reactivity is not 
confused with unstained fibers. 
In an overlay of striatal patches with the Kir2.3 image (Fig. 22B, D) the low Kir2.3 
immunoreactivity inside the patch compartment is verified. The lines surrounding the 
patches nicely correspond to the borders between areas of different Kir2.3 staining 
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intensities. Thus, there is a clear correlation between areas with increased Kir2.3 
immunoreactivity and the striatal matrix compartment. 
 
 
Fig. 22: Correspondence between the striatal patch compartments and areas with reduced Kir2.3 
immunoreactivity. For direct correlation, areas of reduced Kir2.3 immunoreactivity (B,D) and the 
striatal patch compartment as visualized by µ-opiate receptor staining (A,C) are compared in 
adjacent sections. In (B,D) areas occupied by fiber bundles are hatched to avoid confusion. The patch 
compartment (as seen in A and C) is outlined in black to facilitate comparison. 
 
3.4.4 Kir2.4 channel subunits are localized at cholinergic interneurons 
In addition to the striatal patch compartment, cholinergic interneurons represent a major 
decision making component within the basal ganglia circuitry. Localization of one of the 
Kir2 channel subfamily members in these giant interneurons would imply their importance 
in the regulation of basal ganglia circuitry. 
A survey micrograph (Fig. 23A) shows large Kir2.4-positive neurons (arrows) dominating 
the minor immunoreactivity of spiny projection neurons. Due to their large size and small 
number these cells most likely represent aspiny cholinergic interneurons. To verify this 
assumption, striatal cholinergic neurons were identified by the presence of choline 
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acetyltransferase (ChAT), the enzyme that catalyses the formation of acetylcholine from 
acetyl-CoA and choline. 
 
 
Fig. 23: Kir2.4 channel immunoreactivity is most prominent in large striatal interneurons. 
Immunoreactivity for the Kir2.4 subunit in the rat striatum is mostly somatodendritic and largely 
absent from the neuropil (A). Staining is weak, however, in the large population of small striatal 
neurons and prominent in only a few, very large cells (A, arrows; B), most likely representing the so-
called ‘giant’ interneurons in the striatum. Immunoreactivity is abolished (C) subsequent to 
preincubation of anti-Kir2.4 antibodies with the cognate protein. 
 
Double labeling experiments (Fig. 24) confirmed the staining of cholinergic interneurons 
by the anti-Kir2.4 antibody. Under red fluorescence the microscopic image displays about 
five different neurons expressing Kir2.4 channel proteins (Fig. 24B, arrowheads). Green 
ChAT immunoreactivity presents a similar distribution of neurons (Fig. 24A). One single 
small cell, weakly stained for Kir2.4 (arrow in B), remained immunonegative for ChAT. 
The expression of Kir2.4 channels at cholinergic interneurons is verified by the yellow 
color of labeled neurons in the overlay image (Fig. 24C). The single smaller cell displays 
a red fluorescence only (Fig. 24C, arrow). Most probably it represents a spiny striatal 
projection neuron devoid of ChAT immunoreactivity. In addition to the Kir2.4 channel 
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protein, the Kir2.2 subunit was also localized to cholinergic interneurons, confirming data 
from in situ hybridization experiments (see discussion). 
 
Fig. 24: Immunofluorescence double labeling of large striatal interneurons for choline 
acetyltransferase (ChAT) and Kir2.4 immunoreactivity. Sections were treated simultaneously with 
monoclonal mouse anti-ChAT- and rabbit anti-Kir2.4-antibodies, followed by visualization with 
Oregon Green-labeled goat anti-mouse and Texas Red-labeled goat anti-rabbit secondary antibodies. 
The four ChAT-positive cholinergic neurons (A) express Kir2.4-immunoreactivity (B, arrowheads) as 
judged from their yellowish appearance (C) after double exposition for green and red fluorescence. 
 
The expression of Kir2 channels at ChAT neurons was confirmed at the electron 
microscopic level, also focusing on subcellular channel distribution. For this purpose 
cholinergic interneurons were labeled with anti-ChAT antibodies and visualized via 
peroxidase and diaminobenzidine. Anti-Kir2.2 and anti-Kir2.4 antibodies were detected 
using gold-labeled secondary antibodies. Both Kir2 subfamily members were localized at 
cholinergic interneurons (Fig. 25). 
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Fig. 25: Double labeling of Kir2.4 and choline acetyltransferase at the electron microscopic level. 
Cholinergic interneurons are identified by their amorphous diaminobenzidine reaction product (A, 
arrows) in single- (A) or double-stained sections. Kir2 immunoreactivity is visualized by silver-
intensified ultrasmall gold particles (for details see methods). Cholinergic interneurons display Kir2.2 
(B) as well as Kir2.4 (C) immunoreactivity. 
 
DAB-positive cholinergic neurons were recognized by dark cytoplasmic deposits (Fig. 
25A, arrows). In double labeling experiments, gold dots indicated the localization of 
Kir2.2 (Fig. 25B) and Kir2.4 (Fig. 25C) channel subunits. Note that there are some gold 
dots outside the cholinergic interneuron in anti-Kir2.2- but not in anti-Kir2.4-stained 
sections. Thus, only Kir2.4-immunoreactivity was found to be restricted to cholinergic 
inter-neurons, offering possibilities for specific, Kir2.4-based modulation of the striatal 
cholinergic system with potential therapeutic consequences. 
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4 Discussion 
Potassium channels are important components of the signal transduction machinery of the 
nervous system and virtually all other cells of the mammalian body. They are involved in 
a wide variety of functions such as setting and stabilizing the resting potential of most cell 
types or regulating the depolarization time course in pacemaker cells. Other parameters 
like action potential duration, firing frequencies, and interspike intervals are also 
determined by the activity of potassium channels76. A functional channel is formed by the 
homomeric or heteromeric aggregation of four subunit proteins, usually from members of 
one channel family. The basic structural organisation of such a subunit consists of a short 
amino acid sequence, which forms a “loop” into the membrane and is flanked by two 
transmembrane domains (see Fig. 1B). The loop takes part in forming the channel pore. 
This basic structural unit may be supplemented by four additional membrane spanning 
domains, or two units may be combined to a single protein, thus forming three structural 
classes of potassium channels77. With respect to sequence homologies, each of these 
classes consists of at least six families, again each represented by one to nine members, 
each possibly represented by more than five splice variants. Summing up to about 90 
individual genes with even more functional gene products from different splice variants 
and the formation of heterooligomers, there is an impressive amount of potassium 
channels, large enough to cover the complex range of channel functions in living cells. 
This complexity explains the fact that a variety of quite distinct diseases can be traced 
back to ion channel defects. Thus, Andersen’s syndrome (AS), a rare inherited disorder 
characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features, is due 
to mutations of the Kir2.1 potassium channel78. Furthermore, an increasing number of 
neurological diseases such as hereditary deafness syndromes, episodic ataxia type-1, 
acquired neuromyotonia, and others are the results of compromised potassium channel 
functions79. On the other hand, the large molecular diversity of the channels should allow 
the development of highly specific drugs, which may selectively target cell types, groups, 
or systems throughout the body, correcting or at least improving disturbed functions. The 
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great potential of this approach is documented by the effective treatment of diabetes or 
cardiac arrhythmias with drugs, which are primarily directed to ATP-sensitive or HERG-
type potassium channels, respectively. The impact of this strategy for improving 
neuropsychiatric pharmacotherapy is under consideration80. Systematic development of 
further neuroactive drugs, however, will depend on information about the involvement of 
molecularly defined potassium channels in identified neuronal circuits. In this respect it is 
important to understand the regional, cellular, and subcellular localizations of identified 
potassium channel subunits in clinically important brain nuclei such as the basal ganglia. 
In the present study we generated highly specific, affinity-purified rabbit antibodies to 
study the detailed distribution of Kir2 inwardly rectifying potassium channel subunits in 
the striatum. With respect to a potential involvement of Kir2 channels in motor output of 
the basal ganglia, we focused on the striatal key structures for movement regulation. In 
particular, we asked whether any of the Kir2 channels are selectively distributed in the 
patch or matrix compartment of the striatum or preferentially localized at cholinergic 
interneurons. 
 
4.1.1 Kir2 channel proteins are differentially expressed throughout the rat 
brain 
The monospecific antibodies allowed the characterization of Kir2 protein localization in 
the rat central nervous system. The widespread presence of all four Kir2 channel subunits 
in the rat brain may indicate their important role in central signal processing and neural 
transmission. Our data agree with earlier in situ hybridization (ISH) experiments (see 
chapter 3.3.) and electrophysiological studies, confirming the basic distribution patterns of 
Kir2.1, Kir2.2 and Kir2.3 subunits. However, ISH experiments only indicate which 
neurons can synthesize these subunits. Our immunocytochemical experiments extend 
these data, presenting information on the subcellular localization in the different types of 
neurons. Exemplary in the basal ganglia, all Kir2 subunits are localized in the somata and 
dendrites of striatal neurons. Data obtained so far suggest that Kir2.2 is the only member 
of this channel family, which is additionally sorted to the axonal plasma membrane. 
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Regional and cellular localizations of the Kir2.4 subunit, as presented here, contrast an 
earlier in situ hybridization study by Töpert et al. 1998, where Kir2.4 mRNA was reported 
to be primarily expressed in neurons of cranial nerve motor nuclei. The present 
investigation reveals a widespread Kir2.4 immunoreactivity among neurons in many brain 
areas (see chapter 3.3.). In all areas the signal was blocked by preabsorption of antibodies 
with its cognate recombinant protein, ruling out background labeling. Another difference 
is the Kir2.4 localization in the rat striatum, where no Kir2.4 transcripts were detected by 
in situ hybridization81. We found a signal in most, if not all striatal neurons. With the 
exception of the cholinergic interneurons, however, Kir2.4 immunoreactivity is less 
intense as compared to the other members of the Kir2 subfamily. 
The apparent contradiction may be, however, simply due to aspects of sensitivity. We also 
find very strong labeling of brain stem motor neurons (Fig. 17-VII,J), where Kir2.4 
mRNA was reported to be primarily expressed, but we detect weaker expression in most 
neurons throughout the brain. Our data, therefore, support the prominent localization of 
Kir2.4 protein in motor nuclei. Interestingly enough, motor neurons are cholinergic as are 
the giant interneurons in the striatum. This raises the possibility that cholinergic neurons 
in general may preferentially use the Kir2.4 subunit to control their resting potentials. 
Further investigation of other cholinergic cell groups in the vertebrate CNS should 
provide more decisive information. 
The sensitivity aspect is supported by experiments with the rat retina. Kir2.4 transcripts82 
and proteins83 were clearly detected in the retina, while Töpert et al. did not find any 
Kir2.4 mRNA expression in this organ. These data strengthen our hypothesis of a more 
widespread Kir2.4 localization as supported by Töpert’s study. 
The detailed channel protein distribution of all members of the Kir2 subfamily in the rat 
brain is summarized in table 4. Excellent agreement of the Kir2.1-Kir2.3 subunit (for 
Kir2.4 see above mentioned comments) with former in situ hybridization experiments84 
was found in most brain regions, for example olfactory bulb, olfactory tubercle, neocortex, 
hippocampus, caudate putamen, nucleus accumbens, lateral olfactory tract nucleus, 
hypothalamus, habenula and superior colliculus (Fig. 17-I – 17-IX). But in some areas 
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there are differing distribution patterns of mRNA and channel protein expression. The 
most obvious difference was observed in the hindbrain, where the Kir2.1 and Kir2.3 
subunits were reported to be virtually absent85. In contrast to their report and in strong 
agreement with a previous mRNA study on the Kir2.3 subunit86, we found the distribution 
of the Kir2.3 channel subunit extended to cerebellar Purkinje cells and to neurons of the 
deep cerebellar nuclei (Fig. 17-VIII,E/I). The Kir2.1 subunit was also detected in the 
cerebellum (molecular layer and deep nuclei), which is supported by a former localization 
study87. Nevertheless, the cerebellar expression of the Kir2.2 protein with very high 
signals in the granule cell layer is confirmed in our investigation.  
Another difference was found in the thalamus (Fig. 17-V). Although the Kir2.2, Kir2.3 
and Kir2.4 channel distribution is similar to the previously described mRNA localization 
pattern, the Kir2.1 protein was found at significant levels in various thalamic nuclei, 
thereby contrasting former investigations88. Finally, we observed expression of all four 
members of the Kir2 subfamily in the substantia nigra, where only the Kir2.2 subunit was 
reported to be expressed89. In fact, the Kir2.2 channel protein was present in markedly 
elevated levels, but also the Kir2.3 subunit displayed specific signals mainly in the pars 
reticulata.   
4.1.2 The Kir2.3 subunit is preferentially expressed in striatal matrix 
neurons 
All members of the Kir2 subfamily are differentially distributed throughout the rat 
striatum, thus confirming the fundamental localization pattern as reported from previous 
in situ hybridization experiments (see table 5). The broad distribution of all Kir2 channels 
suggests important roles for these channels in regulating neuronal excitation and 
transmission within the basal ganglia circuitry. 
The present study demonstrates an inhomogeneous distribution of potassium channels in 
the striatum. Thus, one member of the inwardly rectifying Kir2 family, namely the Kir2.3 
channel protein in the rat striatum, displays a heterogeneous pattern that can neither be 
explained by varying cell densities nor by the numerous fiber bundles. Instead, the density 
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of the inwardly rectifying potassium channels nicely correlates with the striatal 
compartments. The Kir2.3 channel tends to avoid the patch compartment and is 
predominantly expressed in the striatal matrix.  
An inhomogeneous distribution of Kir2.3 channels in the striatum was inferred from 
Surmeier’s group90 using single-cell RT-PCR and whole-cell patch clamp techniques. 
They found a preferential expression of Kir2.1, Kir2.2 and Kir2.3 channels in either SubP-
positive or Enk-positive medium spiny neurons. The Kir2.3 channel was expressed in all 
SubP-positive neurons but only in a minority of Enk-positive cells. Thus, the discovered 
distribution pattern refers to the distinction between direct and indirect pathway of striatal 
signal transduction (see chapter 1.2.3.). Extending these data, our results illuminate a 
difference between the striatal patch and matrix compartment. 
 
 
Fig. 26: Ratios of patch neurons to matrix neurons across embryonic ages. Ratios above the solid 
horizontal line indicate a predominance of patch neuron birthdates and ratios below the line indicate 
a predominance of matrix neuron birthdates. Consequently, at the time of beginning Kir2.3 mRNA 
expression most of the neurons end up in the matrix compartment. 
 
The preferential localization of the Kir2.3 subunit in the striatal matrix compartment is in 
agreement with developmental studies. Thus, most of early born neurons (becoming 
postmitotic between E12-E16) end up in the patch, while the majority of later born 
neurons (E18-postnatal day P2) mature in the matrix compartment91. Correspondingly, 
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onset of Kir2.3 channel expression begins late, and Kir2.3 mRNA is absent from the brain 
until E2192. Apparently, at the time when striatal neurons start expressing Kir2.3 channel 
proteins, these neurons are still in development and there is an extraordinarily high 
probability that they will end up in the matrix compartment (Fig. 26). Of course, not only 
developing neurons express Kir2.3 channels. But Kir’s evident influence in development 
of trophic interaction and synaptogenesis93 suggests an electrophysiological involvement 
as early as necessary. 
Inwardly rectifying Kir2 channels dominate the electrophysiological behavior in the 
down-state of medium spiny neurons94 (see chapter 1.2.1) by keeping the membrane 
potential close to the K+ equilibrium potential. Based upon our studies, in matrix neurons 
this is mainly done by the Kir2.3 channel. Thus, the amount and activity of Kir2.3 
channels determine the membrane conductance in matrix medium spiny cells. It is well 
known that the transition to the up-state and following spike generation depends on 
temporally coherent excitatory synaptic input. If the cells express a high number of Kir2.3 
potassium channels, massive convergent input is necessary to generate the up-state. 
Consequently, it may be expected that pharmacologically blocked Kir2.3 channels fail to 
stabilize the neuronal down-state. 
The matrix-related basal ganglia loops are thought to transmit effectory signals, i.e. the 
motor output. In contrast, patch-related circuitry mainly accounts for the regulation of the 
motor effects. Application of a selective Kir2.3 channel blocking drug could facilitate 
spiking within the matrix compartment by excitatory input while the patch might be 
virtually unaffected due to their absent Kir2.3 expression. Therefore, blocking of Kir2.3 
channels may specifically improve the motor outcome (for example bradykinesia) in 
Parkinson’s disease. 
 
4.1.3 Kir2.4 immunoreactivity in the striatum is most prominently displayed 
by the giant cholinergic interneurons 
Although anti-Kir2.4 antibodies react with many neurons in the striatum, they most 
intensely stain the giant interneurons. The cholinergic nature of these neurons was 
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confirmed by double labeling experiments at the light and electron microscopic level. 
Cholinergic interneurons also display the Kir2.2 subunit, but only at a level comparable to 
that in the spiny projection neurons. Our results are supported by the Kir2.2 mRNA 
distribution as reported recently95. 
Bearing in mind the pivotal role of cholinergic neurons for the motor outcome of neuronal 
computations in basal ganglia, Kir2.4 subunit containing potassium channels, due to their 
restricted localization, may be especially important. They will take part not only in 
controlling the activity of the interneurons, but may be further involved in regulating the 
fine tuning between the two basal ganglia pathways. Thus, cholinergic interneurons are 
known96 to activate the spiny projection neurons of the indirect pathway via M1 receptors 
(see introduction). M1-based stimulation of these neurons should be additionally 
facilitated by the concomitant destabilization of the resting potential due to an inhibition 
of Kir2.3 channel activity inherent to M1 receptor activation97. 
 
4.1.4 Can Kir channel subunits be targets for novel therapeutic strategies? 
As mentioned above, a variety of distinct diseases can be traced back to ion channel 
defects. This is also confirmed in the special case of inwardly rectifying potassium 
channels. Mutations in genes encoding Kir channels have been shown to cause hereditary 
diseases. Salt-wasting and metabolic acidosis in Bartter’s syndrome98 often is due to the 
malfunction of ROMK1 (Kir1.1) channels in the kidney. Degeneration of cerebellar 
granule cells with resulting ataxia is due to Kir3.2 missense mutations in weaver mice99. 
However, only little progress has been made in supporting recent therapeutic strategies by 
targeting Kir channel subunits. This may be primarily due to the fact that our knowledge 
on the detailed biological functions of Kir channels in the nervous system is still limited. 
Some natural drugs affecting Kir channel activity like the Kir1.1/Kir3.1-specific channel 
inhibitor tertiapin100 and the spermine-like Kir blocker Philanthotoxin101 are available. 
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These are hopeful beginnings on the way to specifically treating Kir channel-based 
diseases. 
Inwardly rectifying potassium channels can be attractive candidates for novel therapeutic 
regimes only if the channels are selectively expressed in those nervous structures that are 
important for any neuropsychiatric disorder or for side effects during established 
treatment. In that case, activation or inhibition of Kir channels may influence the clinical 
situation of affected patients. The present study reports the Kir2 channel localization to 
defined structures of the basal ganglia circuits, which are basically involved in the 
regulation of movements. Patch and matrix striatal compartments as well as the 
cholinergic interneurons represent these key structures and display a specific distribution 
pattern of Kir2 channel subunits. 
Pharmacological manipulations of potassium channels will extend available interactions 
with transmitter systems. Thus, selective activation of Kir2.4-subunit containing channels 
in the striatum will stabilize the resting potential of giant cholinergic interneurons. 
Consequently, action potential firing and cholinergic transmission will be reduced in a 
manner comparable with the application of an anticholinergic drug. Because of the 
influence restricted to the interneuron, however, diverse side effects of anticholinergic 
therapy may be absent or reduced. It could not be expected, of course, that simply 
targeting Kir2.4 channels in the striatum by channel openers or blockers would affect only 
motor behavior without side effects on other neurons. However, it is conceivable to use 
such drugs at subthreshold doses. Thus, on their own, such treatments may remain without 
obvious pharmacological effects. Combination with again subthreshold doses of a second 
drug, however, which affect striatal ChAT neurons via a distinct mechanism, for instance 
other channels102, should cause an effect above threshold. 
Pharmacological intervention with neurotransmission within the matrix and patch 
compartments of the striatum seems to be more complex with respect to the predominant 
Kir2.3 expression in the matrix. Increasing membrane excitability by inhibiting Kir 
channels may partly compensate the problems of dopamine-deficiency such as akinesia, 
tremor, or rigor in parkinsonian states. 
Matrix inputs in most areas of the striatum are predominantly related to sensorimotor 
processing, whereas patch input has a strong relation to the limbic system. Keeping in 
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mind these functional compartmental differences, a Kir2.3-mediated activation or 
inhibition of matrix neurons may predominantly influence motor circuits within the basal 
ganglia, leaving limbic circuits mainly unaffected. Thus, targeting Kir2.3 channels may 
participate in an improved neuroleptic therapy. Aiming at motor and not at limbic circuits 
may disconnect the antipsychotic effects of neuroleptics from their severe motor side 
effects, such as early and late dyskinesias as well as parkinsonoid syndromes.  
Additional examination of limbic circuits will be required to provide further information. 
The nucleus accumbens seems to connect motor outcome with the limbic system 
(“limbic/motor interface”) and plays a major role in mediating motivation and reward103. 
It contains two subdivisions, shell and core, which are cytoarchitectonically and 
pharmacologically distinct and differ also in their afferent and efferent connections104. The 
present investigation revealed the expression of all four Kir2 subfamily members in the 
nucleus accumbens (Fig. 17-IV). Interestingly, the Kir2.3 subunit displayed a patchy 
distribution in the core part resembling the striatal expression pattern and supporting the 
strong histochemical relation between core and striatum105. Moreover, particularly 
elevated signals of the Kir2.3 channel protein in the shell part of the nucleus accumbens 
suggest profound involvement in the neuronal excitability and regulation at this site of 
limbic/motor interaction. Therefore, a more detailed analysis of ventromedial striatal areas 
and the nucleus accumbens is in progress in our laboratory. 
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Summary 
Parkinson’s disease is the most frequent movement disorder caused by loss of 
dopaminergic neurons in the midbrain. Intentions to avoid side effects of conventional 
therapy should aim to identify additional targets for potential pharmacological 
intervention. In principle, every step of a signal transduction cascade, such as presynaptic 
transmitter release, type and occupation of postsynaptic receptors, G protein-mediated 
effector mechanisms, and the alterations of pre- or postsynaptic potentials as determined 
by the local ion channel composition, have to be considered. Due to their diversity and 
their widespread but distinct localizations, potassium channels represent interesting 
candidates for new therapeutic strategies. 
As a first step, the present report aimed to study the cellular and subcellular distribution of 
the individual members of the Kir2 family in the striatum, a group of proteins forming 
inwardly rectifying potassium channels. For this purpose polyclonal, monospecific, 
affinity purified antibodies against the less conserved carboxyterminal sequences from the 
Kir2.1, Kir2.2, Kir2.3, and Kir2.4 proteins were prepared. All subunits of the Kir2 family 
were detected on somata and dendrites of most striatal neurons. However, the distribution 
of two of them was not homogeneous. Striatal patch areas were largely devoid of the 
Kir2.3 protein, and the Kir2.4 subunit was most prominently expressed on the tonically 
active, giant cholinergic interneurons of the striatum. These two structures are among the 
key players in regulating dopaminergic and cholinergic neurotransmission within the 
striatum, and therefore are of major importance for the output of the basal ganglia. The 
heterogeneous localization of the Kir2.3 and the Kir2.4 subunits with respect to these 
strategic structures pinpoints these channel proteins as promising targets for future 
pharmacological efforts. 
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